<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Genet</journal-id>
<journal-id journal-id-type="publisher-id">Front. Genet.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Genetics</journal-title>
</journal-title-group>
<issn pub-type="epub">1664-8021</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31788001</article-id>
<article-id pub-id-type="pmc">6855267</article-id>
<article-id pub-id-type="doi">10.3389/fgene.2019.01092</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Genetics</subject>
<subj-group>
<subject>Hypothesis and Theory</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Chromosome Instability and Mosaic Aneuploidy in Neurodegenerative and Neurodevelopmental Disorders</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Potter</surname>
<given-names>Huntington</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>†</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/99843" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chial</surname>
<given-names>Heidi J.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>†</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/834108/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Caneus</surname>
<given-names>Julbert</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/826364/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Elos</surname>
<given-names>Mihret</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/833231/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Elder</surname>
<given-names>Nina</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/808289" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Borysov</surname>
<given-names>Sergiy</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/832488/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Granic</surname>
<given-names>Antoneta</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/825969" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup><institution>Department of Neurology, Rocky Mountain Alzheimer’s Disease Center, University of Colorado</institution>, <addr-line>Aurora, CO</addr-line>, <country>United States</country></aff>
<aff id="aff2">
<sup>2</sup><institution>Linda Crnic Institute for Down Syndrome, University of Colorado</institution>, <addr-line>Aurora, CO</addr-line>, <country>United States</country></aff>
<aff id="aff3">
<sup>3</sup><institution>NanoScience Technology Center, University of Central Florida</institution>, <addr-line>Orlando, FL</addr-line>, <country>United States</country></aff>
<aff id="aff4">
<sup>4</sup><institution>Department of Math and Science, Saint Leo University</institution>, <addr-line>Saint Leo, FL</addr-line>, <country>United States</country></aff>
<aff id="aff5">
<sup>5</sup><institution>AGE Research Group, Institute of Neuroscience, Newcastle University</institution>, <addr-line>Newcastle upon Tyne</addr-line>, <country>United Kingdom</country></aff>
<aff id="aff6">
<sup>6 </sup><institution>Newcastle University Institute for Ageing, NIHR Newcastle Biomedical Research Centre</institution>, <addr-line>Newcastle upon Tyne</addr-line>, <country>United Kingdom</country></aff>
<aff id="aff7">
<sup>7</sup><institution>Newcastle upon Tyne Hospitals, NHS Foundation Trust</institution>, <addr-line>Newcastle upon Tyne</addr-line>, <country>United Kingdom</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Svetlana G. Vorsanova, Russian National Research Medical University, Russia</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Vladan Bajic, University of Belgrade, Serbia; Thomas Liehr, Friedrich Schiller University Germany; Thomas Arendt, Leipzig University, Germany</p>
</fn>
<corresp id="fn001">*Correspondence: Huntington Potter, <email xlink:href="mailto:huntington.potter@cuanschutz.edu" xlink:type="simple">huntington.potter@cuanschutz.edu</email>
</corresp>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Human Genomics, a section of the journal Frontiers in Genetics</p>
</fn>
<fn fn-type="equal" id="fn003">
<p>†These authors have contributed equally to this work</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>07</day>
<month>11</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>10</volume>
<elocation-id>1092</elocation-id>
<history>
<date date-type="received">
<day>12</day>
<month>9</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>09</day>
<month>10</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2019 Potter, Chial, Caneus, Elos, Elder, Borysov and Granic</copyright-statement>
<copyright-year>2019</copyright-year>
<copyright-holder>Potter, Chial, Caneus, Elos, Elder, Borysov and Granic</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Evidence from multiple laboratories has accumulated to show that mosaic neuronal aneuploidy and consequent apoptosis characterizes and may underlie neuronal loss in many neurodegenerative diseases, particularly Alzheimer’s disease and frontotemporal dementia. Furthermore, several neurodevelopmental disorders, including Seckel syndrome, ataxia telangiectasia, Nijmegen breakage syndrome, Niemann–Pick type C, and Down syndrome, have been shown to also exhibit mosaic aneuploidy in neurons in the brain and in other cells throughout the body. Together, these results indicate that both neurodegenerative and neurodevelopmental disorders with apparently different pathogenic causes share a cell cycle defect that leads to mosaic aneuploidy in many cell types. When such mosaic aneuploidy arises in neurons in the brain, it promotes apoptosis and may at least partly underlie the cognitive deficits that characterize the neurological symptoms of these disorders. These findings have implications for both diagnosis and treatment/prevention.</p>
</abstract>
<kwd-group>
<kwd>Alzheimer’s disease</kwd>
<kwd>Mosaic aneuploidy</kwd>
<kwd>Frontotemporal lobar degeneration</kwd>
<kwd>Neuronal apoptosis</kwd>
<kwd>Huntington’s disease (HD)</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">National Institutes of Health<named-content content-type="fundref-id">10.13039/100000002</named-content></funding-source>
</award-group>
</funding-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="0"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="131"></ref-count>
<page-count count="10"></page-count>
<word-count count="4453"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Age-associated neurodegenerative diseases exhibit different brain pathologies and different clinical features, and all are associated with reduced neuronal numbers in specific brain regions. Furthermore, when caused by a mutation, each disorder evidently involves a unique pathogenic pathway because the mutant proteins are usually involved in very different physiological processes. Indeed, the normal function of the associated mutant gene should provide insights into that specific disease’s pathogenic pathway. For example, the mutations that cause autosomal dominant familial Alzheimer’s disease (FAD) arise in only three genes: the amyloid precursor protein (<italic>APP</italic>) gene, the presenilin 1 (<italic>PSEN1</italic>) gene, and the presenilin 2 (<italic>PSEN2</italic>) gene, all three of which encode proteins involved in the production of the Aβ peptide, which is the main pathogenic molecule of AD (<xref ref-type="bibr" rid="B34">Goate and Hardy, 2012</xref>; <xref ref-type="bibr" rid="B38">Hardy, 2017</xref>). Specifically, PSEN1 and PSEN2 are components of the γ-secretase complex, which, together with the β-secretase enzyme, cleaves APP to release Aβ. In contrast, patients with frontotemporal dementia (also called frontotemporal lobar degeneration, FTLD) exhibit clinical and pathological characteristics that differ from AD, and most of the autosomal dominantly inherited familial forms of FTLD are caused by a mutation in the <italic>MAPT/Tau</italic> gene, by a mutation in the progranulin (<italic>PRGN</italic>) gene, or by a triplet repeat expansion in the <italic>C9ORF72</italic> gene, all three of which carry out vastly different normal functions in the cell and are also unrelated to the genes mutated in FAD (<xref ref-type="bibr" rid="B88">Rademakers et al., 2012</xref>). Interestingly, in some families, instead of or in addition to FTLD, the triplet repeat expansion in the <italic>C9ORF72</italic> gene can cause familial amyotrophic lateral sclerosis, a motor neuron degenerative disease that is associated with cognitive decline only during later stages of the disease. Huntington’s disease similarly exhibits a unique pathology and clinical course and is caused by a triplet repeat expansion in the huntingtin (<italic>HTT</italic>) gene, whose normal function is also apparently different from any of the genes associated with familial forms of AD or FTLD (<xref ref-type="bibr" rid="B81">Podvin et al., 2019</xref>). Thus, there appears to be no common feature of neurodegenerative disorders beyond the fact that they all result in neuronal loss.</p>
<p>Neurodevelopmental disorders are associated with different pathologies and clinical phenotypes, although they again usually include microcephaly or another indication of a defect in neurogenesis or neuronal survival. For example, ataxia telangiectasia and the related disorder Seckel syndrome are caused by mutations in the <italic>ATM</italic> and <italic>ATR</italic> genes, respectively, which encode two related protein kinases. Because both ataxia telangiectasia and Seckel syndrome appear to involve the loss of neurons, they might be considered neurodegenerative disorders without an essential aging component associated with their underlying mechanisms. Down syndrome also results in reduced neuronal numbers in key brain regions during development, and, interestingly, every person with Down syndrome develops AD brain neuropathology by age 30–40, which usually leads to dementia by age 50–60 (<xref ref-type="bibr" rid="B39">Hartley et al., 2015</xref>; <xref ref-type="bibr" rid="B40">Hithersay et al., 2019</xref>).</p>
<p>Because these multiple disorders have different pathologies and different clinical symptoms and they involve different pathogenic pathways, as evidenced by the different genes in which causal mutations can arise, it is reasonable to hypothesize that each disorder is distinct and would require different approaches to therapy and prevention. However, if it were possible to identify a key step that is shared among the pathogenic pathways of many neurodegenerative and/or neurodevelopmental disorders, then it would also be reasonable to hypothesize that insights into the causal mechanism might be gained and the potential for a common approach to the development of new therapies might be recognized. Of course, any shared mechanistic features that are identified must also be considered as potentially a mere correlate of the degenerative process rather than as an <italic>essential</italic> step in the pathogenic pathways. To distinguish between these two hypotheses, the strength of the genetics can be exploited because it is self-evident that a direct effect of a mutant gene is likely to be part of the causal mechanism. If multiple neurodevelopmental and neurodegenerative disease-causing mutations impact a common pathogenic step, then that step should be considered a potential key to preventing the neurodegeneration and should thus serve as a prime target for the development of therapeutic interventions that could be applied to multiple disorders.</p>
<p>Over the past decade, we and others have identified a potential common step in the pathogenic pathways that lead to multiple distinct neurodegenerative and neurodevelopmental disorders. Specifically, mutations in genes linked to many of these disorders have been shown to lead to chromosome segregation defects and mosaic aneuploidy in cell types throughout the body, including in brain neurons, which likely contributes to the neuronal cell loss/apoptosis that underlies their neurological features.</p>
<sec id="s1_1">
<title>Mosaic Aneuploidy in Alzheimer’s Disease</title>
<p>Mosaic aneuploidy/hyperploidy, including trisomy 21, was first hypothesized (<xref ref-type="bibr" rid="B82">Potter, 1991</xref>) and has been most thoroughly investigated in AD (<xref ref-type="bibr" rid="B32">Geller and Potter, 1999</xref>; <xref ref-type="bibr" rid="B120">Yang et al., 2001</xref>; <xref ref-type="bibr" rid="B55">Kingsbury et al., 2006</xref>; <xref ref-type="bibr" rid="B70">Mosch et al., 2007</xref>; <xref ref-type="bibr" rid="B112">Thomas and Fenech, 2008</xref>; <xref ref-type="bibr" rid="B45">Iourov et al., 2009b</xref>; <xref ref-type="bibr" rid="B7">Arendt et al., 2010</xref>; <xref ref-type="bibr" rid="B47">Iourov et al., 2011</xref>). Arendt and colleagues’ extensive study of brains from AD patients showed that 20–30% of brain neurons are aneuploid during the early preclinical stages of AD and that their specific loss in later stages of the disease can account for 90% of the neuronal atrophy observed at autopsy (<xref ref-type="bibr" rid="B7">Arendt et al., 2010</xref>). Somatic mosaic aneuploidy can also be detected in cells from peripheral tissues of AD patients, including fibroblasts, peripheral blood mononuclear cells, and buccal cells (<xref ref-type="bibr" rid="B84">Potter et al., 1995</xref>; <xref ref-type="bibr" rid="B67">Migliore et al., 1997</xref>; <xref ref-type="bibr" rid="B32">Geller and Potter, 1999</xref>; <xref ref-type="bibr" rid="B66">Migliore et al., 1999</xref>; <xref ref-type="bibr" rid="B113">Trippi et al., 2001</xref>; <xref ref-type="bibr" rid="B112">Thomas and Fenech, 2008</xref>), providing an opportunity for early detection.</p>
<p>The specific finding that trisomy 21 mosaicism occurs in many tissues in AD patients, including in the brain, is highly relevant because people with Down syndrome are usually fully trisomic for chromosome 21 due to chromosome mis-segregation during meiosis, every person with Down syndrome develops AD brain neuropathology by 35 years of age, the majority of people with Down syndrome develop AD dementia by age 60, and nearly all people with Down syndrome who die after age 35 have dementia (<xref ref-type="bibr" rid="B33">Glenner and Wong, 1984</xref>; <xref ref-type="bibr" rid="B117">Wisniewski et al., 1985</xref>; <xref ref-type="bibr" rid="B27">Epstein, 1990</xref>; <xref ref-type="bibr" rid="B39">Hartley et al., 2015</xref>; <xref ref-type="bibr" rid="B40">Hithersay et al., 2019</xref>). The <italic>APP</italic> gene is located on chromosome 21, and its presence in three copies in Down syndrome is presumed to underlie the development of early-onset AD in this population (<xref ref-type="bibr" rid="B39">Hartley et al., 2015</xref>). Support for this conclusion comes from the observation that individuals who carry an FAD mutation in the <italic>APP</italic> gene or who have three copies of the <italic>APP</italic> gene due to a local duplication on one chromosome (<xref ref-type="bibr" rid="B97">Rovelet-Lecrux et al., 2006</xref>; <xref ref-type="bibr" rid="B106">Sleegers et al., 2006</xref>) will develop autosomal-dominant early-onset AD. Furthermore, individuals who only have 1–10% trisomy 21 cells and show no features of Down syndrome also develop early-onset, sporadic AD dementia, suggesting that even low levels of trisomy 21 mosaicism can lead to AD (reviewed in <xref ref-type="bibr" rid="B82">Potter, 1991</xref>). Evidence that three copies of the <italic>APP</italic> gene are not only <italic>sufficient</italic> but also <italic>necessary</italic> to cause AD is provided by the fact that rare individuals who have full trisomy 21 and all of the clinical and physiological features of Down syndrome but have only two copies of the <italic>APP</italic> gene due to a localized deletion on chromosome 21 fail to develop AD symptoms or AD pathology even at an old age (<xref ref-type="bibr" rid="B86">Prasher et al., 1998</xref>; <xref ref-type="bibr" rid="B25">Doran et al., 2017</xref>).</p>
<p>Evidence that an underlying susceptibility to chromosome segregation defects may be associated with an increased risk of AD was first provided by a study showing that women who were 35 or younger when they gave birth to a child with Down syndrome have a fivefold increased risk of developing AD later in life compared to control mothers or compared to mothers who gave birth to a child with Down syndrome after age 35 (<xref ref-type="bibr" rid="B101">Schupf et al., 1994</xref>). More direct support for the idea that both trisomy 21 and AD are associated with an underlying predisposition for chromosome mis-segregation comes from a study of cultured peripheral blood lymphocytes from mothers under the age of 35 who gave birth to a child with Down syndrome (<xref ref-type="bibr" rid="B65">Migliore et al., 2006</xref>). In that study, they used fluorescence in situ hybridization probes for chromosomes 21 and 13 and observed significantly higher levels of chromosome non-disjunction involving both chromosomes within the first cell cycle in the lymphocytes from mothers who gave birth to a child with Down syndrome compared to control mothers who had not had a miscarriage and whose children did not have genetic disorders (<xref ref-type="bibr" rid="B65">Migliore et al., 2006</xref>). Taken together, these findings suggest that an underlying predisposition for chromosome instability may lead to increased AD risk.</p>
<p>The association of chromosome instability and aneuploidy with AD has been reinforced by mechanistic studies. The key proteins whose mutant genes cause the majority of FAD—the presenilin proteins (PSEN1 and PSEN2) and the amyloid precursor protein (APP)—localize to centromeres/kinetochores, centrosomes, and/or the nuclear envelope (<xref ref-type="bibr" rid="B58">Li et al., 1997</xref>; <xref ref-type="bibr" rid="B5">Annaert et al., 1999</xref>; <xref ref-type="bibr" rid="B41">Honda et al., 2000</xref>; <xref ref-type="bibr" rid="B50">Jeong et al., 2000</xref>; <xref ref-type="bibr" rid="B54">Kimura et al., 2001</xref>; <xref ref-type="bibr" rid="B75">Nizzari et al., 2007a</xref>; <xref ref-type="bibr" rid="B76">Nizzari et al., 2007b</xref>; <xref ref-type="bibr" rid="B123">Young-Pearse et al., 2010</xref>; <xref ref-type="bibr" rid="B51">Judge et al., 2011</xref>). Furthermore, FAD mutations in <italic>PSEN1</italic> or <italic>APP</italic> cause mitotic spindle abnormalities and aneuploidy in transgenic mice and in transfected cells (<xref ref-type="bibr" rid="B14">Boeras et al., 2008</xref>; <xref ref-type="bibr" rid="B35">Granic et al., 2010</xref>). Treatment of karyotypically normal cells with oligomeric Aβ peptide, which is the product of PSEN1- and PSEN2-dependent cleavage of APP, also disrupts the mitotic spindle and induces chromosome mis-segregation and aneuploidy by competitively inhibiting certain microtubule motors, particularly Kinesin-5/KIF11/Eg5, MCAK/KIF2C, and KIF4A, in both cell culture experiments and in <italic>Xenopus</italic> egg extracts (<xref ref-type="bibr" rid="B14">Boeras et al., 2008</xref>; <xref ref-type="bibr" rid="B17">Borysov et al., 2011</xref>). These mechanistic studies established that cell cycle defects and the resultant mosaic aneuploidy are a direct effect of FAD mutant genes and are thus likely to be part of the AD pathogenic pathway and not merely a correlate of neurodegeneration in the brain.</p>
<p>The role of chromosome aneuploidy in AD suggests that studying mechanisms that regulate mitosis may lead to novel insights into AD. For example, Shugoshin-1 (SGO1) encodes a protein that is involved in chromosome cohesion and is needed for normal chromosome segregation, and SGO1 haploinsufficiency leads to chromosome missegregation and tumorigenesis (<xref ref-type="bibr" rid="B119">Yamada et al., 2012</xref>). Building on the role of aneuploidy in AD, Rao and Yamada and colleagues hypothesized that <italic>SGO1</italic> heterozygous knockout mice may serve as a potential model of sporadic late-onset AD, and they indeed discovered some AD-related pathology as the mice aged, which was associated with prolonged mitosis and spindle checkpoint activation (<xref ref-type="bibr" rid="B90">Rao et al., 2018a</xref>; <xref ref-type="bibr" rid="B91">Rao et al., 2018b</xref>).</p>
</sec>
<sec id="s1_2">
<title>Mosaic Aneuploidy in Frontotemporal Lobar Degeneration</title>
<p>In addition to AD, mosaic aneuploidy has been observed in FTLD (<xref ref-type="bibr" rid="B95">Rossi et al., 2013</xref>; <xref ref-type="bibr" rid="B94">Rossi et al., 2014</xref>; <xref ref-type="bibr" rid="B21">Caneus et al., 2018</xref>). In earlier studies, mosaic aneuploidy was reported in skin fibroblasts and peripheral blood lymphocytes from FTLD patients and in splenic lymphocytes from mouse models of FTLD-MAPT (<xref ref-type="bibr" rid="B96">Rossi et al., 2008</xref>; <xref ref-type="bibr" rid="B95">Rossi et al., 2013</xref>; <xref ref-type="bibr" rid="B94">Rossi et al., 2014</xref>). In the subsequent study, we found mosaic aneuploidy and associated apoptosis in both neuronal and non-neuronal brain cells from patients with familial FTLD who carry a mutation in the <italic>MAPT/Tau</italic> gene (<xref ref-type="bibr" rid="B21">Caneus et al., 2018</xref>). Expression of FTLD-causing mutant MAPT induced mitotic spindle abnormalities, chromosome mis-segregation, aneuploidy, and apoptosis in neurons and other cells in the brains of transgenic mice and in transfected cells (<xref ref-type="bibr" rid="B21">Caneus et al., 2018</xref>). Furthermore, we showed in our FTLD study that apoptosis occurs in the same brain neurons that are aneuploid and that, in cultured cells expressing FTLD-causing mutant forms of human MAPT, apoptosis follows and depends upon aneuploidy-generating cell cycle defects (<xref ref-type="bibr" rid="B21">Caneus et al., 2018</xref>). If the cell cycle is blocked by inhibiting the interaction between MDM2 and p53 by treatment with low doses of Nutlin-3 at 24 h after expression of FTLD-causing mutant MAPT, no aneuploid cells arise (<xref ref-type="bibr" rid="B21">Caneus et al., 2018</xref>). Importantly, treatment with Nutlin-3 also blocks apoptosis, indicating that the toxicity of mutant MAPT depends on cells aberrantly proceeding through the cell cycle and becoming aneuploid.</p>
<p>Evidence linking neuronal aneuploidy, neurodegeneration, and MAPT was reported recently by two other groups in <italic>Drosophila</italic> models of FTLD. Specifically, a study by Bougé and Parmentier showed that excess Tau causes mitotic spindle defects, aneuploidy, and apoptosis in neurons by inhibiting the microtubule-dependent motor protein Kinesin-5 (<xref ref-type="bibr" rid="B18">Bouge and Parmentier, 2016</xref>). Similar results have been reported by Malmanche et al. who examined photoreceptors and brain neurons in <italic>Drosophila</italic> and found that adult-onset neurodegeneration mediated by MAPT overexpression included the generation of aneuploid cells (<xref ref-type="bibr" rid="B62">Malmanche et al., 2017</xref>). The former result is of particular interest in view of our previous finding that Aβ induces chromosome mis-segregation and aneuploidy by competitively inhibiting the activity of Kinesin-5/KIF11/Eg5 (<xref ref-type="bibr" rid="B17">Borysov et al., 2011</xref>). Thus, causal mutations leading to AD and FTLD-MAPT appear to lead to chromosome mis-segregation, aneuploidy, and apoptosis through inhibition of the same target enzyme: Kinesin-5/KIF11/Eg5.</p>
<p>In addition to MAPT-FTLD, we have found that mosaic neuronal aneuploidy and dependent apoptosis are also characteristic of brains of individuals with sporadic FTLD or with FTLD caused by mutations in <italic>PRGN</italic> or by triplet repeat expansions in <italic>C9ORF72</italic> (Elos and Caneus et al., unpublished results, manuscript in preparation).</p>
<p>It is likely that other neurodegenerative diseases are also associated with mosaic aneuploidy in the brain. For example, autism spectrum disorder (<xref ref-type="bibr" rid="B127">Yurov et al., 2007</xref>; <xref ref-type="bibr" rid="B49">Iourov et al., 2008</xref>), ataxia telangiectasia (<xref ref-type="bibr" rid="B63">McConnell et al., 2004</xref>; <xref ref-type="bibr" rid="B44">Iourov et al., 2009a</xref>; <xref ref-type="bibr" rid="B45">Iourov et al., 2009b</xref>), and Lewy body disease, which includes Parkinson’s disease (<xref ref-type="bibr" rid="B121">Yang et al., 2015</xref>), have all been reported to exhibit either general hyperploidy or mosaic aneuploidy for numerous chromosomes in brain and/or peripheral tissues. Our laboratory also has preliminary evidence for mosaic aneuploidy in both brain cells and fibroblasts from Huntington’s disease patients (Elos and Caneus et al., unpublished results, manuscript in preparation).</p>
</sec>
<sec id="s1_3">
<title>Mosaic Aneuploidy in Neurodevelopmental Disorders</title>
<p>Mosaic aneuploidy in neurons and other types of cells also characterizes neurodevelopmental disorders. For example, loss-of-function mutations in the ataxia telangiectasia mutated and Rad3-related (ATR) encoded kinase cause Seckel syndrome, a rare autosomal recessive disorder characterized by pre- and postnatal growth delays, microcephaly, and intellectual disability. Loss of ATR function and of the related kinase ataxia telangiectasia mutated (ATM) have been linked to defective DNA repair, which has been assumed to cause the genomic instability, including aneuploidy, observed in these disorders and to make ataxia telangiectasia patients prone to cancer (<xref ref-type="bibr" rid="B118">Wright et al., 1998</xref>; <xref ref-type="bibr" rid="B109">Spring et al., 2002</xref>; <xref ref-type="bibr" rid="B103">Shen et al., 2005</xref>; <xref ref-type="bibr" rid="B72">Murga et al., 2009</xref>; <xref ref-type="bibr" rid="B57">Lang et al., 2016</xref>; <xref ref-type="bibr" rid="B122">Yazinski and Zou, 2016</xref>; <xref ref-type="bibr" rid="B13">Blackford and Jackson, 2017</xref>; <xref ref-type="bibr" rid="B87">Quek et al., 2017</xref>). Previous studies showed that ATR localizes to centrosomes (<xref ref-type="bibr" rid="B128">Zhang et al., 2007</xref>) and that loss of ATR function causes centrosome overduplication (<xref ref-type="bibr" rid="B2">Alderton et al., 2004</xref>; <xref ref-type="bibr" rid="B24">Collis et al., 2008</xref>; <xref ref-type="bibr" rid="B110">Stiff et al., 2016</xref>) and genomic instability (<xref ref-type="bibr" rid="B22">Casper et al., 2004</xref>; <xref ref-type="bibr" rid="B69">Mokrani-Benhelli et al., 2013</xref>). In a recent study, Kabeche and colleagues reported a mechanism by which loss of ATR function leads to chromosome mis-segregation and aneuploidy (<xref ref-type="bibr" rid="B52">Kabeche et al., 2018</xref>; <xref ref-type="bibr" rid="B99">Saldivar and Cimprich, 2018</xref>). Specifically, they elegantly demonstrated that ATR localizes to centromeres and is required for proper chromosome segregation, in addition to and <italic>independent of</italic> its roles in DNA damage repair and replication stress responses (<xref ref-type="bibr" rid="B52">Kabeche et al., 2018</xref>). Although not discussed by Kabeche and colleagues or in previous publications, the links between ATR and mitosis provide an explanation for how reduced ATR function and subsequent aneuploidy may underlie the neuronal cell loss during development that leads to microcephaly and cognitive dysfunction, the major clinical, pathological, and disabling features of Seckel syndrome: reduced ATR function results in aneuploidy that leads to neuronal apoptosis.</p>
<p>In addition to Seckel syndrome, mosaic aneuploidy has been observed in brain neurons in ataxia telangiectasia itself (<xref ref-type="bibr" rid="B46">Iourov et al., 2007</xref>; <xref ref-type="bibr" rid="B44">Iourov et al., 2009a</xref>; <xref ref-type="bibr" rid="B45">Iourov et al., 2009b</xref>) and in Niemann–Pick type C disease (<xref ref-type="bibr" rid="B36">Granic and Potter, 2013</xref>), and in peripheral cells in Nijmegen breakage syndrome (<xref ref-type="bibr" rid="B114">Vessey et al., 1999</xref>; <xref ref-type="bibr" rid="B105">Shimada et al., 2009</xref>; <xref ref-type="bibr" rid="B104">Shimada et al., 2010</xref>; <xref ref-type="bibr" rid="B42">Hou et al., 2012</xref>), Fanconi anemia (<xref ref-type="bibr" rid="B73">Nalepa et al., 2013</xref>), and xeroderma pigmentosum (<xref ref-type="bibr" rid="B3">Amiel et al., 2004</xref>). All of these developmental disorders are characterized by microcephaly or other evidence of poor neurogenesis and/or of neuronal loss, and all are associated with cognitive disfunction.</p>
</sec>
<sec id="s1_4">
<title>Mechanisms by Which Neuronal Aneuploidy and Apoptosis Can Arise</title>
<p>Because neurons have been traditionally considered to be post-mitotic (<xref ref-type="bibr" rid="B11">Bhardwaj et al., 2006</xref>), it has been unclear how extensive mosaic aneuploidy can arise in neurodegenerative or neurodevelopmental disorders. More recently, it has become appreciated that neurogenesis is more widespread than previously thought and that the capacity for neurogenesis continues into old age, even if not normally utilized (<xref ref-type="bibr" rid="B129">Zhao et al., 2008</xref>; <xref ref-type="bibr" rid="B108">Spalding et al., 2013</xref>; <xref ref-type="bibr" rid="B15">Boldrini et al., 2018</xref>; <xref ref-type="bibr" rid="B107">Sorrells et al., 2018</xref>). In the adult brain, three processes have been identified that may generate the neuronal aneuploidy observed at autopsy in patients with AD, FTLD-MAPT, and other neurodegenerative and neurodevelopmental disorders. In principle, the generation and accumulation of aneuploidy in dividing or regenerating cell populations might arise by both genetic and environmental stressors at any time in life (discussed in <xref ref-type="bibr" rid="B82">Potter, 1991</xref>; <xref ref-type="bibr" rid="B78">Oromendia and Amon, 2014</xref>). Indeed, there is strong evidence that neurogenesis can occur throughout life in several regions of the brain (<xref ref-type="bibr" rid="B129">Zhao et al., 2008</xref>; <xref ref-type="bibr" rid="B71">Mu and Gage, 2011</xref>; <xref ref-type="bibr" rid="B108">Spalding et al., 2013</xref>; <xref ref-type="bibr" rid="B29">Ernst et al., 2014</xref>). Furthermore, data from many studies provide evidence that neurogenesis can be induced in many brain regions in adult mice and rats in response to brain damage and attempted self-repair by the brain (<xref ref-type="bibr" rid="B131">Zhou et al., 2004</xref>; <xref ref-type="bibr" rid="B129">Zhao et al., 2008</xref>; <xref ref-type="bibr" rid="B108">Spalding et al., 2013</xref>; <xref ref-type="bibr" rid="B130">Zheng et al., 2013</xref>; <xref ref-type="bibr" rid="B43">Ibrahim et al., 2016</xref>), or as part of an ongoing process in the sub-ventricular/granular zone of the brain (<xref ref-type="bibr" rid="B28">Eriksson et al., 1998</xref>; <xref ref-type="bibr" rid="B37">Hallbergson et al., 2003</xref>; <xref ref-type="bibr" rid="B98">Sakamoto et al., 2014</xref>). Thus, neuronal damage and the mitotic defects evident in AD, FTLD-MAPT, and other neurodegenerative and neurodevelopmental disorders could result in the production of new aneuploid neurons, which would not be fully functional and would be particularly prone to apoptosis and degeneration. Indeed, aneuploidy has been shown to promote cell death, including neurodegeneration, in many experimental systems (<xref ref-type="bibr" rid="B89">Rajendran et al., 2008</xref>; <xref ref-type="bibr" rid="B53">Kai et al., 2009</xref>; <xref ref-type="bibr" rid="B7">Arendt et al., 2010</xref>; <xref ref-type="bibr" rid="B78">Oromendia and Amon, 2014</xref>).</p>
<p>The second potential mechanism for the generation of neuronal aneuploidy in neurodegenerative disease is cell cycle reentry. Neurons in the AD brain express phospho-proteins usually detected only during mitosis, such as cyclin B1, cyclin D1, cdc2, and Ki67 (<xref ref-type="bibr" rid="B116">Vincent et al., 1996</xref>; <xref ref-type="bibr" rid="B64">McShea et al., 1997</xref>; <xref ref-type="bibr" rid="B115">Vincent et al., 1997</xref>; <xref ref-type="bibr" rid="B120">Yang et al., 2001</xref>; <xref ref-type="bibr" rid="B6">Arendt, 2012</xref>). In AD mice, the loss of preexisting neurons induces the remaining neurons to reenter the cell cycle (<xref ref-type="bibr" rid="B59">Lopes et al., 2009</xref>). Indeed, Aβ has been shown to induce the expression of mitotic proteins and cell cycle reentry in mature neurons in culture (<xref ref-type="bibr" rid="B61">Majd et al., 2008</xref>; <xref ref-type="bibr" rid="B1">Absalon et al., 2013</xref>; <xref ref-type="bibr" rid="B102">Seward et al., 2013</xref>), which we have confirmed (Nina Elder, unpublished observation).</p>
<p>The third potential mechanism for generating aneuploid neurons is based on the recent discovery that striatal astrocytes can transdifferentiate into new neurons capable of forming functional neuronal circuits with preexisting neurons following ischemic brain injury (<xref ref-type="bibr" rid="B60">Magnusson et al., 2014</xref>; <xref ref-type="bibr" rid="B26">Duan et al., 2015</xref>). This finding suggests that at least some of the aneuploid neurons in AD and FTLD-MAPT brains may be derived from the aneuploid glia that we have shown are present in our preliminary and published studies. In additional preliminary studies, we have found that low numbers of primary astrocytes exposed to Aβ in culture can begin to express the neuronal marker NeuN (Nina Elder, unpublished observation). Taken together, these findings provide evidence that aneuploidy can arise <italic>de novo</italic> in mature neurons by cell cycle reactivation or can be carried over from previously dividing cells that generate new neurons. It is reasonable that age may exacerbate all of these processes because neuronal and non-neuronal aneuploidy have been shown to increase with age (<xref ref-type="bibr" rid="B8">Arendt et al., 2009</xref>; <xref ref-type="bibr" rid="B124">Yurov et al., 2009</xref>; <xref ref-type="bibr" rid="B125">Yurov et al., 2010</xref>; <xref ref-type="bibr" rid="B31">Fischer et al., 2012</xref>; <xref ref-type="bibr" rid="B30">Fantin et al., 2019</xref>). Aging is also associated with increasing total exposure to environmental stressors, some of which can promote chromosome missegregation and aneuploidy (for reviews, see <xref ref-type="bibr" rid="B82">Potter, 1991</xref>; <xref ref-type="bibr" rid="B48">Iourov et al., 2013</xref>).</p>
<p>In addition to the close and mechanistic association between aneuploidy and induced apoptosis discussed above, multiple reports in different systems have shown that aneuploid or other copy number variant cells are prone to degeneration/apoptosis (<xref ref-type="bibr" rid="B78">Oromendia and Amon, 2014</xref>; <xref ref-type="bibr" rid="B77">Ohashi et al., 2015</xref>; <xref ref-type="bibr" rid="B83">Potter et al., 2016</xref>; <xref ref-type="bibr" rid="B4">Andriani et al., 2017</xref>; <xref ref-type="bibr" rid="B23">Chronister et al., 2019</xref>). As mentioned earlier, Arendt and colleagues conducted a pathological study of AD patients’ brains across the disease spectrum and showed that neuronal aneuploidy arises before neurodegeneration or clinical symptoms are evident (<xref ref-type="bibr" rid="B7">Arendt et al., 2010</xref>). Specifically, they found that the number of aneuploid neurons increases steadily from around 10% in normal controls to around 30% during the early preclinical stages of AD and then declines back to around 10% during the transition from preclinical AD to severe AD when neuronal loss occurs. In addition, they calculated that the loss of aneuploid, but not diploid, neurons accounted for 90% of the neuronal atrophy observed at autopsy of late-stage AD brains (<xref ref-type="bibr" rid="B7">Arendt et al., 2010</xref>). Based on their findings, it can be concluded that: 1) aneuploidy in neurons arises in the AD brain before extensive neuronal cell loss occurs and thus the aneuploidy is not likely to be caused by neurodegeneration/neuronal apoptosis, and 2) the vast majority of later neuronal cell loss selectively affects aneuploid neurons, indicating that the neurodegeneration is likely caused by a cell-autonomous cell cycle defect in the neurons themselves rather than by a tissue-wide mechanism (such as an unidentified, diffusible toxic insult released from damaged cells). Possible cell-autonomous effects of aneuploidy that could contribute to cell death include DNA replication stress (<xref ref-type="bibr" rid="B126">Yurov et al., 2011</xref>) and proteotoxic stress (<xref ref-type="bibr" rid="B79">Oromendia et al., 2012</xref>).</p>
</sec>
<sec id="s1_5">
<title>Linking Development and Aging: A Role for Catalysts in Age-Associated Proteinopathies</title>
<p>In view of these considerations, we note that developmental disorders, such as Seckel syndrome, ataxia telangiectasia, Niemann–Pick type C, Nijmegen breakage syndrome, Fanconi anemia, and xeroderma pigmentosum, all of which lead to neuronal apoptosis, degeneration, and microcephaly, result from mutations in genes whose products impact mitosis, directly or indirectly. In contrast, aging-associated neurodegenerative diseases, such as AD, FTLD, Lewy body disease (<xref ref-type="bibr" rid="B121">Yang et al., 2015</xref>), and potentially Huntington’s disease (<xref ref-type="bibr" rid="B100">Sathasivam et al., 2001</xref>; Elos and Caneus et al., unpublished results) and prion disease (<xref ref-type="bibr" rid="B10">Basu et al., 1998</xref>; <xref ref-type="bibr" rid="B16">Borchsenius et al., 2000</xref>; <xref ref-type="bibr" rid="B74">Nieznanska et al., 2012</xref>) all develop abnormal protein deposits in the brain in addition to aneuploidy. The formation of these deposits apparently involves not only the seminal protein itself but often requires inflammation or other aging-associated catalysts. For example, inheritance of the ε4 allele of the apolipoprotein E (<italic>APOE</italic>) gene is the strongest risk factor for the development of AD besides age itself. Interestingly, the <italic>APOE4</italic> allele and an AD-linked <italic>PSEN1</italic> polymorphism have each been shown to increase the risk of meiosis II chromosome segregation errors, leading to Down syndrome, and a mother carrying both the <italic>APOE4</italic> allele and the <italic>PSEN1</italic> polymorphism has an even higher risk of a trisomy 21 conception (<xref ref-type="bibr" rid="B9">Avramopoulos et al., 1996</xref>; <xref ref-type="bibr" rid="B80">Petersen et al., 2000</xref>; <xref ref-type="bibr" rid="B92">Rodriguez-Manotas et al., 2007</xref>; <xref ref-type="bibr" rid="B12">Bhaumik et al., 2017</xref>). Indeed, a recent study of older adults with Down syndrome reported that those who were <italic>APOE4</italic> carriers were at increased risk of both dementia and death (<xref ref-type="bibr" rid="B40">Hithersay et al., 2019</xref>). Notably, ApoE, particularly ApoE4, catalyzes the conversion of Aβ into the toxic oligomers that directly disrupt the mitotic spindle and chromosome segregation and also leads to amyloid deposition (<xref ref-type="bibr" rid="B85">Potter and Wisniewski, 2012</xref>). A similar co-pathological protein likely exists in prion disease too, although this exacerbating protein has been shown not to be ApoE (<xref ref-type="bibr" rid="B111">Tatzelt et al., 1996</xref>). This two-hit mechanism involving a mutant aggregation-prone protein plus an amyloid catalyst may underlie the fact that, in AD, amyloid deposits, symptoms, and aneuploidy all arise with aging. Similar two-hit mechanisms may underlie other aging-associated neurodegenerative diseases and neurodevelopmental disorders. Furthermore, the region-specific expression of the second hit (such as with ApoE in AD) may underlie the region-specific pathology and neuronal loss in different disorders.</p>
</sec>
<sec id="s1_6">
<title>Constitutional Aneuploidy in the Normal Brain</title>
<p>In addition to its association with neurodegenerative and neurodevelopmental disorders, aneuploidy and possibly copy number variations on a smaller scale are considered potential contributors to diversity in brain function (<xref ref-type="bibr" rid="B45">Iourov et al., 2009b</xref>; <xref ref-type="bibr" rid="B68">Mkrtchyan et al., 2010</xref>; <xref ref-type="bibr" rid="B19">Bushman and Chun, 2013</xref>; <xref ref-type="bibr" rid="B93">Rohrback et al., 2018</xref>). Although extensive whole chromosome aneuploidy has not been found by all investigators (<xref ref-type="bibr" rid="B56">Knouse et al., 2014</xref>), it is likely that new methods will reveal more aneuploid cells in both normal aged and diseased brains (<xref ref-type="bibr" rid="B20">Caneus et al., 2017</xref>).</p>
</sec>
<sec id="s1_7">
<title>Summary</title>
<p>In sum, recent work reinforces our emerging understanding of the important role that chromosome mis-segregation and mosaic aneuploidy in neurons may play in an ever-growing list of both neurodevelopmental disorders and aging-associated neurodegenerative disorders (Figure 1). These findings have potentially important implications for the development of: 1) novel diagnoses because, as discussed, in addition to neurons in the brain, peripheral cells also exhibit mosaic aneuploidy in these disorders, and 2) innovative preventions/treatments because interventions can now be sought that specifically promote correct chromosome segregation in the presence of aneugenic mutations and/or aneugenic protein structures that lead to neuropathogenesis.</p>
<fig id="f1" position="float">
<label>Figure 1</label>
<caption>
<p>How mosaic aneuploidy may lead to neuronal loss in neurodegenerative and neurodevelopmental disorders. Shown is a schematic of how mosaic aneuploidy may occur in neurons leading to apoptosis and cognitive deficits in neurodevelopmental and aging-associated neurodegenerative disorders. Seckel syndrome (<italic>SS</italic>), ataxia telangiectasia (<italic>AT</italic>), Niemann–Pick type C disease (<italic>NPC</italic>), Nijmegen breakage syndrome (<italic>NBS</italic>), Fanconi anemia (<italic>FA</italic>), xeroderma pigmentosum (<italic>XP</italic>), Down syndrome (<italic>DS</italic>), Alzheimer’s disease (<italic>AD</italic>), frontotemporal lobar degeneration (<italic>FTLD</italic>), Lewy body disease (<italic>LBD</italic>), and Huntington’s disease (<italic>HD</italic>).</p>
</caption>
<graphic xlink:href="fgene-10-01092-g001"></graphic>
</fig>
</sec>
</sec>
<sec id="s2" sec-type="data-availability">
<title>Data Availability Statement</title>
<p>The datasets generated for this study are available on request to the corresponding author.</p>
</sec>
<sec id="s3">
<title>Author Contributions</title>
<p>All authors contributed to the design and/or execution of the experiments. HP and HC wrote the manuscript. JC primarily designed the figure.</p>
</sec>
<sec id="s4">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>Relevant research was supported by the Alzheimer’s Association, the NIH (AG026711; AG037942; NS072076; AG21886), and private donors.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Absalon</surname><given-names>S.</given-names></name><name><surname>Kochanek</surname><given-names>D. M.</given-names></name><name><surname>Raghavan</surname><given-names>V.</given-names></name><name><surname>Krichevsky</surname><given-names>A. M.</given-names></name></person-group> (<year>2013</year>). <article-title>MiR-26b, upregulated in Alzheimer’s disease, activates cell cycle entry, tau-phosphorylation, and apoptosis in postmitotic neurons</article-title>. <source/>J. Neurosci.
<volume>33</volume> (<issue>37</issue>), <fpage>14645</fpage>–<lpage>14659</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1327-13.2013</pub-id>
<pub-id pub-id-type="pmid">24027266</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Alderton</surname><given-names>G. K.</given-names></name><name><surname>Joenje</surname><given-names>H.</given-names></name><name><surname>Varon</surname><given-names>R.</given-names></name><name><surname>Borglum</surname><given-names>A. D.</given-names></name><name><surname>Jeggo</surname><given-names>P. A.</given-names></name><name><surname>O’Driscoll</surname><given-names>M.</given-names></name></person-group> (<year>2004</year>). <article-title>Seckel syndrome exhibits cellular features demonstrating defects in the ATR-signalling pathway</article-title>. <source/>Hum. Mol. Genet.
<volume>13</volume> (<issue>24</issue>), <fpage>3127</fpage>–<lpage>3138</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddh335</pub-id>
<pub-id pub-id-type="pmid">15496423</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Amiel</surname><given-names>A.</given-names></name><name><surname>Peretz</surname><given-names>G.</given-names></name><name><surname>Slor</surname><given-names>H.</given-names></name><name><surname>Weinstein</surname><given-names>G.</given-names></name><name><surname>Fejgin</surname><given-names>M. D.</given-names></name></person-group> (<year>2004</year>). <article-title>Molecular cytogenetic parameters in fibroblasts from patients and carriers of xeroderma pigmentosum</article-title>. <source/>Cancer Genet. Cytogenet.
<volume>149</volume> (<issue>2</issue>), <fpage>154</fpage>–<lpage>160</lpage>. <pub-id pub-id-type="doi">10.1016/j.cancergencyto.2003.07.004</pub-id>
<pub-id pub-id-type="pmid">15036891</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Andriani</surname><given-names>G. A.</given-names></name><name><surname>Vijg</surname><given-names>J.</given-names></name><name><surname>Montagna</surname><given-names>C.</given-names></name></person-group> (<year>2017</year>). <article-title>Mechanisms and consequences of aneuploidy and chromosome instability in the aging brain</article-title>. <source/>Mech. Ageing Dev.
<volume>161</volume> (<issue>Pt A</issue>), <fpage>19</fpage>–<lpage>36</lpage>. <pub-id pub-id-type="doi">10.1016/j.mad.2016.03.007</pub-id>
<pub-id pub-id-type="pmid">27013377</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Annaert</surname><given-names>W. G.</given-names></name><name><surname>Levesque</surname><given-names>L.</given-names></name><name><surname>Craessaerts</surname><given-names>K.</given-names></name><name><surname>Dierinck</surname><given-names>I.</given-names></name><name><surname>Snellings</surname><given-names>G.</given-names></name><name><surname>Westaway</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>1999</year>). <article-title>Presenilin 1 controls gamma-secretase processing of amyloid precursor protein in pre-golgi compartments of hippocampal neurons</article-title>. <source/>J. Cell Biol.
<volume>147</volume> (<issue>2</issue>), <fpage>277</fpage>–<lpage>294</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.147.2.277</pub-id>
<pub-id pub-id-type="pmid">10525535</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Arendt</surname><given-names>T.</given-names></name></person-group> (<year>2012</year>). <article-title>Cell cycle activation and aneuploid neurons in Alzheimer’s disease</article-title>. <source/>Mol. Neurobiol.
<volume>46</volume> (<issue>1</issue>), <fpage>125</fpage>–<lpage>135</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-012-8262-0</pub-id>
<pub-id pub-id-type="pmid">22528601</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Arendt</surname><given-names>T.</given-names></name><name><surname>Bruckner</surname><given-names>M. K.</given-names></name><name><surname>Mosch</surname><given-names>B.</given-names></name><name><surname>Losche</surname><given-names>A.</given-names></name></person-group> (<year>2010</year>). <article-title>Selective cell death of hyperploid neurons in Alzheimer’s disease</article-title>. <source/>Am. J. Pathol.
<volume>177</volume> (<issue>1</issue>), <fpage>15</fpage>–<lpage>20</lpage>. <pub-id pub-id-type="doi">10.2353/ajpath.2010.090955</pub-id>
<pub-id pub-id-type="pmid">20472889</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Arendt</surname><given-names>T.</given-names></name><name><surname>Mosch</surname><given-names>B.</given-names></name><name><surname>Morawski</surname><given-names>M.</given-names></name></person-group> (<year>2009</year>). <article-title>Neuronal aneuploidy in health and disease: a cytomic approach to understand the molecular individuality of neurons</article-title>. <source/>Int. J. Mol. Sci.
<volume>10</volume> (<issue>4</issue>), <fpage>1609</fpage>–<lpage>1627</lpage>. <pub-id pub-id-type="doi">10.3390/ijms10041609</pub-id>
<pub-id pub-id-type="pmid">19468329</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Avramopoulos</surname><given-names>D.</given-names></name><name><surname>Mikkelsen</surname><given-names>M.</given-names></name><name><surname>Vassilopoulos</surname><given-names>D.</given-names></name><name><surname>Grigoriadou</surname><given-names>M.</given-names></name><name><surname>Petersen</surname><given-names>M. B.</given-names></name></person-group> (<year>1996</year>). <article-title>Apolipoprotein E allele distribution in parents of Down’s syndrome children</article-title>. <source/>Lancet
<volume>347</volume> (<issue>9005</issue>), <fpage>862</fpage>–<lpage>865</lpage>. <pub-id pub-id-type="doi">10.1016/s0140-6736(96)91346-x</pub-id>
<pub-id pub-id-type="pmid">8622392</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Basu</surname><given-names>J.</given-names></name><name><surname>Williams</surname><given-names>B. C.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Williams</surname><given-names>E. V.</given-names></name><name><surname>Goldberg</surname><given-names>M. L.</given-names></name></person-group> (<year>1998</year>). <article-title>Depletion of a Drosophila homolog of yeast Sup35p disrupts spindle assembly, chromosome segregation, and cytokinesis during male meiosis</article-title>. <source/>Cell Motil. Cytoskeleton
<volume>39</volume> (<issue>4</issue>), <fpage>286</fpage>–<lpage>302</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1097-0169(1998)39:4&lt;286::AID-CM4&gt;3.0.CO;2-1</pub-id>
<pub-id pub-id-type="pmid">9556329</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bhardwaj</surname><given-names>R. D.</given-names></name><name><surname>Curtis</surname><given-names>M. A.</given-names></name><name><surname>Spalding</surname><given-names>K. L.</given-names></name><name><surname>Buchholz</surname><given-names>B. A.</given-names></name><name><surname>Fink</surname><given-names>D.</given-names></name><name><surname>Bjork-Eriksson</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Neocortical neurogenesis in humans is restricted to development</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>103</volume> (<issue>33</issue>), <fpage>12564</fpage>–<lpage>12568</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0605177103</pub-id>
<pub-id pub-id-type="pmid">16901981</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bhaumik</surname><given-names>P.</given-names></name><name><surname>Ghosh</surname><given-names>P.</given-names></name><name><surname>Ghosh</surname><given-names>S.</given-names></name><name><surname>Feingold</surname><given-names>E.</given-names></name><name><surname>Ozbek</surname><given-names>U.</given-names></name><name><surname>Sarkar</surname><given-names>B.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Combined association of Presenilin-1 and Apolipoprotein E polymorphisms with maternal meiosis II error in Down syndrome births</article-title>. <source/>Genet. Mol. Biol.
<volume>40</volume> (<issue>3</issue>), <fpage>577</fpage>–<lpage>585</lpage>. <pub-id pub-id-type="doi">10.1590/1678-4685-GMB-2016-0138</pub-id>
<pub-id pub-id-type="pmid">28767121</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Blackford</surname><given-names>A. N.</given-names></name><name><surname>Jackson</surname><given-names>S. P.</given-names></name></person-group> (<year>2017</year>). <article-title>ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response</article-title>. <source/>Mol. Cell
<volume>66</volume> (<issue>6</issue>), <fpage>801</fpage>–<lpage>817</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2017.05.015</pub-id>
<pub-id pub-id-type="pmid">28622525</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Boeras</surname><given-names>D. I.</given-names></name><name><surname>Granic</surname><given-names>A.</given-names></name><name><surname>Padmanabhan</surname><given-names>J.</given-names></name><name><surname>Crespo</surname><given-names>N. C.</given-names></name><name><surname>Rojiani</surname><given-names>A. M.</given-names></name><name><surname>Potter</surname><given-names>H.</given-names></name></person-group> (<year>2008</year>). <article-title>Alzheimer’s presenilin 1 causes chromosome missegregation and aneuploidy</article-title>. <source/>Neurobiol Aging
<volume>29</volume> (<issue>3</issue>), <fpage>319</fpage>–<lpage>328</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2006.10.027</pub-id>
<pub-id pub-id-type="pmid">17169464</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Boldrini</surname><given-names>M.</given-names></name><name><surname>Fulmore</surname><given-names>C. A.</given-names></name><name><surname>Tartt</surname><given-names>A. N.</given-names></name><name><surname>Simeon</surname><given-names>L. R.</given-names></name><name><surname>Pavlova</surname><given-names>I.</given-names></name><name><surname>Poposka</surname><given-names>V.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Human Hippocampal Neurogenesis Persists throughout Aging</article-title>. <source/>Cell Stem Cell
<volume>22</volume> (<issue>4</issue>), <fpage>589</fpage>–<lpage>599 e585</lpage>. <pub-id pub-id-type="doi">10.1016/j.stem.2018.03.015</pub-id>
<pub-id pub-id-type="pmid">29625071</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Borchsenius</surname><given-names>A. S.</given-names></name><name><surname>Tchourikova</surname><given-names>A. A.</given-names></name><name><surname>Inge-Vechtomov</surname><given-names>S. G.</given-names></name></person-group> (<year>2000</year>). <article-title>Recessive mutations in SUP35 and SUP45 genes coding for translation release factors affect chromosome stability in Saccharomyces cerevisiae</article-title>. <source/>Curr. Genet.
<volume>37</volume> (<issue>5</issue>), <fpage>285</fpage>–<lpage>291</lpage>. <pub-id pub-id-type="doi">10.1007/s002940050529</pub-id>
<pub-id pub-id-type="pmid">10853764</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Borysov</surname><given-names>S. I.</given-names></name><name><surname>Granic</surname><given-names>A.</given-names></name><name><surname>Padmanabhan</surname><given-names>J.</given-names></name><name><surname>Walczak</surname><given-names>C. E.</given-names></name><name><surname>Potter</surname><given-names>H.</given-names></name></person-group> (<year>2011</year>). <article-title>Alzheimer Abeta disrupts the mitotic spindle and directly inhibits mitotic microtubule motors</article-title>. <source/>Cell Cycle
<volume>10</volume> (<issue>9</issue>), <fpage>1397</fpage>–<lpage>1410</lpage>. <pub-id pub-id-type="doi">10.4161/cc.10.9.15478</pub-id>
<pub-id pub-id-type="pmid">21566458</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bouge</surname><given-names>A. L.</given-names></name><name><surname>Parmentier</surname><given-names>M. L.</given-names></name></person-group> (<year>2016</year>). <article-title>Tau excess impairs mitosis and kinesin-5 function, leading to aneuploidy and cell death</article-title>. <source/>Dis. Model Mech.
<volume>9</volume> (<issue>3</issue>), <fpage>307</fpage>–<lpage>319</lpage>. <pub-id pub-id-type="doi">10.1242/dmm.022558</pub-id>
<pub-id pub-id-type="pmid">26822478</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bushman</surname><given-names>D. M.</given-names></name><name><surname>Chun</surname><given-names>J.</given-names></name></person-group> (<year>2013</year>). <article-title>The genomically mosaic brain: aneuploidy and more in neural diversity and disease</article-title>. <source/>Semin Cell Dev. Biol.
<volume>24</volume> (<issue>4</issue>), <fpage>357</fpage>–<lpage>369</lpage>. <pub-id pub-id-type="doi">10.1016/j.semcdb.2013.02.003</pub-id>
<pub-id pub-id-type="pmid">23466288</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Caneus</surname><given-names>J.</given-names></name><name><surname>Granic</surname><given-names>A.</given-names></name><name><surname>Chial</surname><given-names>H. J.</given-names></name><name><surname>Potter</surname><given-names>H.</given-names></name></person-group>, (<year>2017</year>). “<article-title>Using Fluorescence In Situ Hybridization (FISH) Analysis to Measure Chromosome Instability and Mosaic Aneuploidy in Neurodegenerative Diseases</article-title>,” in <source/>Genomic Mosaicism in Neurons and Other Cell Types. Eds. <person-group person-group-type="editor"><name><surname>Frade</surname><given-names>J. M.</given-names></name><name><surname>Gage</surname><given-names>F. H.</given-names></name></person-group> (<publisher-loc>New York, NY</publisher-loc>: <publisher-name>Humana Press</publisher-name>), vol. <fpage>329</fpage>–<lpage>359</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-4939-7280-7</pub-id>
</mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Caneus</surname><given-names>J.</given-names></name><name><surname>Granic</surname><given-names>A.</given-names></name><name><surname>Rademakers</surname><given-names>R.</given-names></name><name><surname>Dickson</surname><given-names>D. W.</given-names></name><name><surname>Coughlan</surname><given-names>C. M.</given-names></name><name><surname>Chial</surname><given-names>H. J.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Mitotic defects lead to neuronal aneuploidy and apoptosis in frontotemporal lobar degeneration caused by MAPT mutations</article-title>. <source/>Mol. Biol. Cell
<volume>29</volume> (<issue>5</issue>), <fpage>575</fpage>–<lpage>586</lpage>. <pub-id pub-id-type="doi">10.1091/mbc.E17-01-0031</pub-id>
<pub-id pub-id-type="pmid">29282277</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Casper</surname><given-names>A. M.</given-names></name><name><surname>Durkin</surname><given-names>S. G.</given-names></name><name><surname>Arlt</surname><given-names>M. F.</given-names></name><name><surname>Glover</surname><given-names>T. W.</given-names></name></person-group> (<year>2004</year>). <article-title>Chromosomal instability at common fragile sites in Seckel syndrome</article-title>. <source/>Am. J. Hum Genet.
<volume>75</volume> (<issue>4</issue>), <fpage>654</fpage>–<lpage>660</lpage>. <pub-id pub-id-type="doi">10.1086/422701</pub-id>
<pub-id pub-id-type="pmid">15309689</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chronister</surname><given-names>W. D.</given-names></name><name><surname>Burbulis</surname><given-names>I. E.</given-names></name><name><surname>Wierman</surname><given-names>M. B.</given-names></name><name><surname>Wolpert</surname><given-names>M. J.</given-names></name><name><surname>Haakenson</surname><given-names>M. F.</given-names></name><name><surname>Smith</surname><given-names>A. C. B.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Neurons with Complex Karyotypes Are Rare in Aged Human Neocortex</article-title>. <source/>Cell Rep.
<volume>26825-835</volume> (<issue>4</issue>), <fpage>e827</fpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2018.12.107</pub-id>
</mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Collis</surname><given-names>S. J.</given-names></name><name><surname>Ciccia</surname><given-names>A.</given-names></name><name><surname>Deans</surname><given-names>A. J.</given-names></name><name><surname>Horejsi</surname><given-names>Z.</given-names></name><name><surname>Martin</surname><given-names>J. S.</given-names></name><name><surname>Maslen</surname><given-names>S. L.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>FANCM and FAAP24 function in ATR-mediated checkpoint signaling independently of the Fanconi anemia core complex</article-title>. <source/>Mol. Cell
<volume>32</volume> (<issue>3</issue>), <fpage>313</fpage>–<lpage>324</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2008.10.014</pub-id>
<pub-id pub-id-type="pmid">18995830</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Doran</surname><given-names>E.</given-names></name><name><surname>Keator</surname><given-names>D.</given-names></name><name><surname>Head</surname><given-names>E.</given-names></name><name><surname>Phelan</surname><given-names>M. J.</given-names></name><name><surname>Kim</surname><given-names>R.</given-names></name><name><surname>Totoiu</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Down Syndrome, Partial Trisomy 21, and Absence of Alzheimer’s Disease: The Role of APP</article-title>. <source/>J. Alzheimers Dis.
<volume>56</volume> (<issue>2</issue>), <fpage>459</fpage>–<lpage>470</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-160836</pub-id>
<pub-id pub-id-type="pmid">27983553</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Duan</surname><given-names>C. L.</given-names></name><name><surname>Liu</surname><given-names>C. W.</given-names></name><name><surname>Shen</surname><given-names>S. W.</given-names></name><name><surname>Yu</surname><given-names>Z.</given-names></name><name><surname>Mo</surname><given-names>J. L.</given-names></name><name><surname>Chen</surname><given-names>X. H.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Striatal astrocytes transdifferentiate into functional mature neurons following ischemic brain injury</article-title>. <source/>Glia
<volume>63</volume> (<issue>9</issue>), <fpage>1660</fpage>–<lpage>1670</lpage>. <pub-id pub-id-type="doi">10.1002/glia.22837</pub-id>
<pub-id pub-id-type="pmid">26031629</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Epstein</surname><given-names>C. J.</given-names></name></person-group> (<year>1990</year>). <article-title>The consequences of chromosome imbalance</article-title>. <source/>Am. J. Med. Genet. Suppl.
<volume>7</volume>, <fpage>31</fpage>–<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.1320370706</pub-id>
<pub-id pub-id-type="pmid">2149968</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Eriksson</surname><given-names>P. S.</given-names></name><name><surname>Perfilieva</surname><given-names>E.</given-names></name><name><surname>Bjork-Eriksson</surname><given-names>T.</given-names></name><name><surname>Alborn</surname><given-names>A. M.</given-names></name><name><surname>Nordborg</surname><given-names>C.</given-names></name><name><surname>Peterson</surname><given-names>D. A.</given-names></name><etal></etal></person-group> (<year>1998</year>). <article-title>Neurogenesis in the adult human hippocampus</article-title>. <source/>Nat. Med.
<volume>4</volume> (<issue>11</issue>), <fpage>1313</fpage>–<lpage>1317</lpage>. <pub-id pub-id-type="doi">10.1038/3305</pub-id>
<pub-id pub-id-type="pmid">9809557</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ernst</surname><given-names>A.</given-names></name><name><surname>Alkass</surname><given-names>K.</given-names></name><name><surname>Bernard</surname><given-names>S.</given-names></name><name><surname>Salehpour</surname><given-names>M.</given-names></name><name><surname>Perl</surname><given-names>S.</given-names></name><name><surname>Tisdale</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Neurogenesis in the striatum of the adult human brain</article-title>. <source/>Cell
<volume>156</volume> (<issue>5</issue>), <fpage>1072</fpage>–<lpage>1083</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2014.01.044</pub-id>
<pub-id pub-id-type="pmid">24561062</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fantin</surname><given-names>C.</given-names></name><name><surname>Moraes Nunes</surname><given-names>K.</given-names></name><name><surname>Brito</surname><given-names>D. V.</given-names></name><name><surname>Moura Carvalho</surname><given-names>N. D.</given-names></name><name><surname>Benzaquem</surname><given-names>D. C.</given-names></name></person-group> (<year>2019</year>). <article-title>Chromosomal Alterations in Patients with Alzheimer Disease in Manaus, Amazonas, Brazil</article-title>. <source/>J. Pharmacy Pharmacol.
<volume>7</volume>, <fpage>451</fpage>–<lpage>458</lpage>. <pub-id pub-id-type="doi">10.17265/2328-2150/2019.08.001</pub-id>
</mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fischer</surname><given-names>H. G.</given-names></name><name><surname>Morawski</surname><given-names>M.</given-names></name><name><surname>Bruckner</surname><given-names>M. K.</given-names></name><name><surname>Mittag</surname><given-names>A.</given-names></name><name><surname>Tarnok</surname><given-names>A.</given-names></name><name><surname>Arendt</surname><given-names>T.</given-names></name></person-group> (<year>2012</year>). <article-title>Changes in neuronal DNA content variation in the human brain during aging</article-title>. <source/>Aging Cell
<volume>11</volume> (<issue>4</issue>), <fpage>628</fpage>–<lpage>633</lpage>. <pub-id pub-id-type="doi">10.1111/j.1474-9726.2012.00826.x</pub-id>
<pub-id pub-id-type="pmid">22510449</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Geller</surname><given-names>L. N.</given-names></name><name><surname>Potter</surname><given-names>H.</given-names></name></person-group> (<year>1999</year>). <article-title>Chromosome missegregation and trisomy 21 mosaicism in Alzheimer’s disease</article-title>. <source/>Neurobiol Dis.
<volume>6</volume> (<issue>3</issue>), <fpage>167</fpage>–<lpage>179</lpage>. <pub-id pub-id-type="doi">10.1006/nbdi.1999.0236</pub-id>
<pub-id pub-id-type="pmid">10408806</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Glenner</surname><given-names>G. G.</given-names></name><name><surname>Wong</surname><given-names>C. W.</given-names></name></person-group> (<year>1984</year>). <article-title>Alzheimer’s disease and Down’s syndrome: sharing of a unique cerebrovascular amyloid fibril protein</article-title>. <source/>Biochem. Biophys Res. Commun.
<volume>122</volume> (<issue>3</issue>), <fpage>1131</fpage>–<lpage>1135</lpage>. <pub-id pub-id-type="doi">10.1016/0006-291x(84)91209-9</pub-id>
<pub-id pub-id-type="pmid">6236805</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Goate</surname><given-names>A.</given-names></name><name><surname>Hardy</surname><given-names>J.</given-names></name></person-group> (<year>2012</year>). <article-title>Twenty years of Alzheimer’s disease-causing mutations</article-title>. <source/>J. Neurochem
<volume>120</volume>
<issue>Suppl 1</issue>, <fpage>3</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2011.07575.x</pub-id>
<pub-id pub-id-type="pmid">22122678</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Granic</surname><given-names>A.</given-names></name><name><surname>Padmanabhan</surname><given-names>J.</given-names></name><name><surname>Norden</surname><given-names>M.</given-names></name><name><surname>Potter</surname><given-names>H.</given-names></name></person-group> (<year>2010</year>). <article-title>Alzheimer Abeta peptide induces chromosome mis-segregation and aneuploidy, including trisomy 21: requirement for tau and APP</article-title>. <source/>Mol. Biol. Cell
<volume>21</volume> (<issue>4</issue>), <fpage>511</fpage>–<lpage>520</lpage>. <pub-id pub-id-type="doi">10.1091/mbc.E09-10-0850</pub-id>
<pub-id pub-id-type="pmid">20032300</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Granic</surname><given-names>A.</given-names></name><name><surname>Potter</surname><given-names>H.</given-names></name></person-group> (<year>2013</year>). <article-title>Mitotic spindle defects and chromosome mis-segregation induced by LDL/cholesterol-implications for Niemann-Pick C1, Alzheimer’s disease, and atherosclerosis</article-title>. <source/>PloS One
<volume>8</volume> (<issue>4</issue>), <fpage>e60718</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0060718</pub-id>
<pub-id pub-id-type="pmid">23593294</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hallbergson</surname><given-names>A. F.</given-names></name><name><surname>Gnatenco</surname><given-names>C.</given-names></name><name><surname>Peterson</surname><given-names>D. A.</given-names></name></person-group> (<year>2003</year>). <article-title>Neurogenesis and brain injury: managing a renewable resource for repair</article-title>. <source/>J. Clin. Invest
<volume>112</volume> (<issue>8</issue>), <fpage>1128</fpage>–<lpage>1133</lpage>. <pub-id pub-id-type="doi">10.1172/JCI20098</pub-id>
<pub-id pub-id-type="pmid">14561695</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hardy</surname><given-names>J.</given-names></name></person-group> (<year>2017</year>). <article-title>The discovery of Alzheimer-causing mutations in the APP gene and the formulation of the “amyloid cascade hypothesis”</article-title>. <source/>FEBS J.
<volume>284</volume> (<issue>7</issue>), <fpage>1040</fpage>–<lpage>1044</lpage>. <pub-id pub-id-type="doi">10.1111/febs.14004</pub-id>
<pub-id pub-id-type="pmid">28054745</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hartley</surname><given-names>D.</given-names></name><name><surname>Blumenthal</surname><given-names>T.</given-names></name><name><surname>Carrillo</surname><given-names>M.</given-names></name><name><surname>DiPaolo</surname><given-names>G.</given-names></name><name><surname>Esralew</surname><given-names>L.</given-names></name><name><surname>Gardiner</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Down syndrome and Alzheimer’s disease: Common pathways, common goals</article-title>. <source/>Alzheimers Dement.
<volume>11</volume> (<issue>6</issue>), <fpage>700</fpage>–<lpage>709</lpage>. <pub-id pub-id-type="doi">10.1016/j.jalz.2014.10.007</pub-id>
<pub-id pub-id-type="pmid">25510383</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hithersay</surname><given-names>R.</given-names></name><name><surname>Startin</surname><given-names>C. M.</given-names></name><name><surname>Hamburg</surname><given-names>S.</given-names></name><name><surname>Mok</surname><given-names>K. Y.</given-names></name><name><surname>Hardy</surname><given-names>J.</given-names></name><name><surname>Fisher</surname><given-names>E. M. C.</given-names></name><etal></etal></person-group> (<year>2019</year>). <article-title>Association of Dementia With Mortality Among Adults With Down Syndrome Older Than 35 Years</article-title>. <source/>JAMA Neurol.
<volume>76</volume> (<issue>2</issue>), <fpage>152</fpage>–<lpage>160</lpage>. <pub-id pub-id-type="doi">10.1001/jamaneurol.2018.3616</pub-id>
<pub-id pub-id-type="pmid">30452522</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Honda</surname><given-names>T.</given-names></name><name><surname>Nihonmatsu</surname><given-names>N.</given-names></name><name><surname>Yasutake</surname><given-names>K.</given-names></name><name><surname>Ohtake</surname><given-names>A.</given-names></name><name><surname>Sato</surname><given-names>K.</given-names></name><name><surname>Tanaka</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2000</year>). <article-title>Familial Alzheimer’s disease-associated mutations block translocation of full-length presenilin 1 to the nuclear envelope</article-title>. <source/>Neurosci. Res.
<volume>37</volume> (<issue>2</issue>), <fpage>101</fpage>–<lpage>111</lpage>. <pub-id pub-id-type="doi">10.1016/s0168-0102(00)00106-1</pub-id>
<pub-id pub-id-type="pmid">10867173</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hou</surname><given-names>Y. Y.</given-names></name><name><surname>Toh</surname><given-names>M. T.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name></person-group> (<year>2012</year>). <article-title>NBS1 deficiency promotes genome instability by affecting DNA damage signaling pathway and impairing telomere integrity</article-title>. <source/>Cell Biochem. Funct.
<volume>30</volume> (<issue>3</issue>), <fpage>233</fpage>–<lpage>242</lpage>. <pub-id pub-id-type="doi">10.1002/cbf.1840</pub-id>
<pub-id pub-id-type="pmid">22161642</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ibrahim</surname><given-names>S.</given-names></name><name><surname>Hu</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Gao</surname><given-names>X.</given-names></name><name><surname>He</surname><given-names>C.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name></person-group> (<year>2016</year>). <article-title>Traumatic Brain Injury Causes Aberrant Migration of Adult-Born Neurons in the Hippocampus</article-title>. <source/>Sci. Rep.
<volume>6</volume>, <fpage>21793</fpage>. <pub-id pub-id-type="doi">10.1038/srep21793</pub-id>
<pub-id pub-id-type="pmid">26898165</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Iourov</surname><given-names>I. Y.</given-names></name><name><surname>Vorsanova</surname><given-names>S. G.</given-names></name><name><surname>Liehr</surname><given-names>T.</given-names></name><name><surname>Kolotii</surname><given-names>A. D.</given-names></name><name><surname>Yurov</surname><given-names>Y. B.</given-names></name></person-group> (<year>2009</year>a). <article-title>Increased chromosome instability dramatically disrupts neural genome integrity and mediates cerebellar degeneration in the ataxia-telangiectasia brain</article-title>. <source/>Hum. Mol. Genet.
<volume>18</volume> (<issue>14</issue>), <fpage>2656</fpage>–<lpage>2669</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddp207</pub-id>
<pub-id pub-id-type="pmid">19414482</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Iourov</surname><given-names>I. Y.</given-names></name><name><surname>Vorsanova</surname><given-names>S. G.</given-names></name><name><surname>Liehr</surname><given-names>T.</given-names></name><name><surname>Yurov</surname><given-names>Y. B.</given-names></name></person-group> (<year>2009</year>b). <article-title>Aneuploidy in the normal, Alzheimer’s disease and ataxia-telangiectasia brain: differential expression and pathological meaning</article-title>. <source/>Neurobiol. Dis.
<volume>34</volume> (<issue>2</issue>), <fpage>212</fpage>–<lpage>220</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2009.01.003</pub-id>
<pub-id pub-id-type="pmid">19344645</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Iourov</surname><given-names>I. Y.</given-names></name><name><surname>Vorsanova</surname><given-names>S. G.</given-names></name><name><surname>Yurov</surname><given-names>Y. B.</given-names></name></person-group> (<year>2007</year>). <article-title>Ataxia telangiectasia paradox can be explained by chromosome instability at the subtissue level</article-title>. <source/>Med. Hypotheses
<volume>68</volume> (<issue>3</issue>), <fpage>716</fpage>. <pub-id pub-id-type="doi">10.1016/j.mehy.2006.09.021</pub-id>
<pub-id pub-id-type="pmid">17069988</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Iourov</surname><given-names>I. Y.</given-names></name><name><surname>Vorsanova</surname><given-names>S. G.</given-names></name><name><surname>Yurov</surname><given-names>Y. B.</given-names></name></person-group> (<year>2011</year>). <article-title>Genomic landscape of the Alzheimer’s disease brain: chromosome instability–aneuploidy, but not tetraploidy–mediates neurodegeneration</article-title>. <source/>Neurodegener. Dis.
<volume>8</volume> (<issue>1-2</issue>), <fpage>35</fpage>–<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1159/000315398</pub-id>
<pub-id pub-id-type="pmid">21135562</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Iourov</surname><given-names>I. Y.</given-names></name><name><surname>Vorsanova</surname><given-names>S. G.</given-names></name><name><surname>Yurov</surname><given-names>Y. B.</given-names></name></person-group> (<year>2013</year>). <article-title>Somatic cell genomics of brain disorders: a new opportunity to clarify genetic-environmental interactions</article-title>. <source/>Cytogenet Genome Res.
<volume>139</volume> (<issue>3</issue>), <fpage>181</fpage>–<lpage>188</lpage>. <pub-id pub-id-type="doi">10.1159/000347053</pub-id>
<pub-id pub-id-type="pmid">23428498</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Iourov</surname><given-names>I. Y.</given-names></name><name><surname>Yurov</surname><given-names>Y. B.</given-names></name><name><surname>Vorsanova</surname><given-names>S. G.</given-names></name></person-group> (<year>2008</year>). <article-title>Mosaic X chromosome aneuploidy can help to explain the male-to-female ratio in autism</article-title>. <source/>Med. Hypotheses
<volume>70</volume> (<issue>2</issue>), <fpage>456</fpage>. <pub-id pub-id-type="doi">10.1016/j.mehy.2007.05.037</pub-id>
<pub-id pub-id-type="pmid">17651908</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jeong</surname><given-names>S. J.</given-names></name><name><surname>Kim</surname><given-names>H. S.</given-names></name><name><surname>Chang</surname><given-names>K. A.</given-names></name><name><surname>Geum</surname><given-names>D. H.</given-names></name><name><surname>Park</surname><given-names>C. H.</given-names></name><name><surname>Seo</surname><given-names>J. H.</given-names></name><etal></etal></person-group> (<year>2000</year>). <article-title>Subcellular localization of presenilins during mouse preimplantation development</article-title>. <source/>FASEB J.
<volume>14</volume> (<issue>14</issue>), <fpage>2171</fpage>–<lpage>2176</lpage>. <pub-id pub-id-type="doi">10.1096/fj.99-1068com</pub-id>
<pub-id pub-id-type="pmid">11053237</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Judge</surname><given-names>M.</given-names></name><name><surname>Hornbeck</surname><given-names>L.</given-names></name><name><surname>Potter</surname><given-names>H.</given-names></name><name><surname>Padmanabhan</surname><given-names>J.</given-names></name></person-group> (<year>2011</year>). <article-title>Mitosis-specific phosphorylation of amyloid precursor protein at threonine 668 leads to its altered processing and association with centrosomes</article-title>. <source/>Mol. Neurodegener
<volume>6</volume>, <fpage>80</fpage>. <pub-id pub-id-type="doi">10.1186/1750-1326-6-80</pub-id>
<pub-id pub-id-type="pmid">22112898</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kabeche</surname><given-names>L.</given-names></name><name><surname>Nguyen</surname><given-names>H. D.</given-names></name><name><surname>Buisson</surname><given-names>R.</given-names></name><name><surname>Zou</surname><given-names>L.</given-names></name></person-group> (<year>2018</year>). <article-title>A mitosis-specific and R loop-driven ATR pathway promotes faithful chromosome segregation</article-title>. <source/>Science
<volume>359</volume> (<issue>6371</issue>), <fpage>108</fpage>–<lpage>114</lpage>. <pub-id pub-id-type="doi">10.1126/science.aan6490</pub-id>
<pub-id pub-id-type="pmid">29170278</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kai</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>C. C.</given-names></name><name><surname>Kishigami</surname><given-names>S.</given-names></name><name><surname>Kazuki</surname><given-names>Y.</given-names></name><name><surname>Abe</surname><given-names>S.</given-names></name><name><surname>Takiguchi</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Enhanced apoptosis during early neuronal differentiation in mouse ES cells with autosomal imbalance</article-title>. <source/>Cell Res.
<volume>19</volume> (<issue>2</issue>), <fpage>247</fpage>–<lpage>258</lpage>. <pub-id pub-id-type="doi">10.1038/cr.2008.305</pub-id>
<pub-id pub-id-type="pmid">19015669</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kimura</surname><given-names>N.</given-names></name><name><surname>Nakamura</surname><given-names>S. I.</given-names></name><name><surname>Honda</surname><given-names>T.</given-names></name><name><surname>Takashima</surname><given-names>A.</given-names></name><name><surname>Nakayama</surname><given-names>H.</given-names></name><etal></etal></person-group>, (<year>2001</year>). <article-title>Age-related changes in the localization of presenilin-1 in cynomolgus monkey brain</article-title>. <source/>Brain Res.
<volume>922</volume> (<issue>1</issue>), <fpage>30</fpage>–<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1016/s0006-8993(01)03146-8</pub-id>
<pub-id pub-id-type="pmid">11730699</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kingsbury</surname><given-names>M. A.</given-names></name><name><surname>Yung</surname><given-names>Y. C.</given-names></name><name><surname>Peterson</surname><given-names>S. E.</given-names></name><name><surname>Westra</surname><given-names>J. W.</given-names></name><name><surname>Chun</surname><given-names>J.</given-names></name></person-group> (<year>2006</year>). <article-title>Aneuploidy in the normal and diseased brain</article-title>. <source/>Cell Mol. Life Sci.
<volume>63</volume> (<issue>22</issue>), <fpage>2626</fpage>–<lpage>2641</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-006-6169-5</pub-id>
<pub-id pub-id-type="pmid">16952055</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Knouse</surname><given-names>K. A.</given-names></name><name><surname>Wu</surname><given-names>J.</given-names></name><name><surname>Whittaker</surname><given-names>C. A.</given-names></name><name><surname>Amon</surname><given-names>A.</given-names></name></person-group> (<year>2014</year>). <article-title>Single cell sequencing reveals low levels of aneuploidy across mammalian tissues</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>111</volume> (<issue>37</issue>), <fpage>13409</fpage>–<lpage>13414</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1415287111</pub-id>
<pub-id pub-id-type="pmid">25197050</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lang</surname><given-names>P. Y.</given-names></name><name><surname>Nanjangud</surname><given-names>G. J.</given-names></name><name><surname>Sokolsky-Papkov</surname><given-names>M.</given-names></name><name><surname>Shaw</surname><given-names>C.</given-names></name><name><surname>Hwang</surname><given-names>D.</given-names></name><name><surname>Parker</surname><given-names>J. S.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>ATR maintains chromosomal integrity during postnatal cerebellar neurogenesis and is required for medulloblastoma formation</article-title>. <source/>Development
<volume>143</volume> (<issue>21</issue>), <fpage>4038</fpage>–<lpage>4052</lpage>. <pub-id pub-id-type="doi">10.1242/dev.139022</pub-id>
<pub-id pub-id-type="pmid">27803059</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Xu</surname><given-names>M.</given-names></name><name><surname>Zhou</surname><given-names>H.</given-names></name><name><surname>Ma</surname><given-names>J.</given-names></name><name><surname>Potter</surname><given-names>H.</given-names></name></person-group> (<year>1997</year>). <article-title>Alzheimer presenilins in the nuclear membrane, interphase kinetochores, and centrosomes suggest a role in chromosome segregation</article-title>. <source/>Cell
<volume>90</volume> (<issue>5</issue>), <fpage>917</fpage>–<lpage>927</lpage>. <pub-id pub-id-type="doi">10.1016/s0092-8674(00)80356-6</pub-id>
<pub-id pub-id-type="pmid">9298903</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lopes</surname><given-names>J. P.</given-names></name><name><surname>Blurton-Jones</surname><given-names>M.</given-names></name><name><surname>Yamasaki</surname><given-names>T. R.</given-names></name><name><surname>Agostinho</surname><given-names>P.</given-names></name><name><surname>LaFerla</surname><given-names>F. M.</given-names></name></person-group> (<year>2009</year>). <article-title>Activation of cell cycle proteins in transgenic mice in response to neuronal loss but not amyloid-beta and tau pathology</article-title>. <source/>J. Alzheimers Dis.
<volume>16</volume> (<issue>3</issue>), <fpage>541</fpage>–<lpage>549</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-2009-0993</pub-id>
<pub-id pub-id-type="pmid">19276549</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Magnusson</surname><given-names>J. P.</given-names></name><name><surname>Goritz</surname><given-names>C.</given-names></name><name><surname>Tatarishvili</surname><given-names>J.</given-names></name><name><surname>Dias</surname><given-names>D. O.</given-names></name><name><surname>Smith</surname><given-names>E. M.</given-names></name><name><surname>Lindvall</surname><given-names>O.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>A latent neurogenic program in astrocytes regulated by Notch signaling in the mouse</article-title>. <source/>Science
<volume>346</volume> (<issue>6206</issue>), <fpage>237</fpage>–<lpage>241</lpage>. <pub-id pub-id-type="doi">10.1126/science.346.6206.237</pub-id>
<pub-id pub-id-type="pmid">25301628</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Majd</surname><given-names>S.</given-names></name><name><surname>Zarifkar</surname><given-names>A.</given-names></name><name><surname>Rastegar</surname><given-names>K.</given-names></name><name><surname>Takhshid</surname><given-names>M. A.</given-names></name></person-group> (<year>2008</year>). <article-title>Different fibrillar Abeta 1-42 concentrations induce adult hippocampal neurons to reenter various phases of the cell cycle</article-title>. <source/>Brain Res.
<volume>1218</volume>, <fpage>224</fpage>–<lpage>229</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2008.04.050</pub-id>
<pub-id pub-id-type="pmid">18533137</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Malmanche</surname><given-names>N.</given-names></name><name><surname>Dourlen</surname><given-names>P.</given-names></name><name><surname>Gistelinck</surname><given-names>M.</given-names></name><name><surname>Demiautte</surname><given-names>F.</given-names></name><name><surname>Link</surname><given-names>N.</given-names></name><name><surname>Dupont</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Developmental Expression of 4-Repeat-Tau Induces Neuronal Aneuploidy in Drosophila Tauopathy Models</article-title>. <source/>Sci. Rep.
<volume>7</volume>, <fpage>40764</fpage>. <pub-id pub-id-type="doi">10.1038/srep40764</pub-id>
<pub-id pub-id-type="pmid">28112163</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>McConnell</surname><given-names>M. J.</given-names></name><name><surname>Kaushal</surname><given-names>D.</given-names></name><name><surname>Yang</surname><given-names>A. H.</given-names></name><name><surname>Kingsbury</surname><given-names>M. A.</given-names></name><name><surname>Rehen</surname><given-names>S. K.</given-names></name><name><surname>Treuner</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Failed clearance of aneuploid embryonic neural progenitor cells leads to excess aneuploidy in the Atm-deficient but not the Trp53-deficient adult cerebral cortex</article-title>. <source/>J. Neurosci.
<volume>24</volume> (<issue>37</issue>), <fpage>8090</fpage>–<lpage>8096</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2263-04.2004</pub-id>
<pub-id pub-id-type="pmid">15371510</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>McShea</surname><given-names>A.</given-names></name><name><surname>Harris</surname><given-names>P. L.</given-names></name><name><surname>Webster</surname><given-names>K. R.</given-names></name><name><surname>Wahl</surname><given-names>A. F.</given-names></name><name><surname>Smith</surname><given-names>M. A.</given-names></name></person-group> (<year>1997</year>). <article-title>Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer’s disease</article-title>. <source/>Am. J. Pathol.
<volume>150</volume> (<issue>6</issue>), <fpage>1933</fpage>–<lpage>1939</lpage>.<pub-id pub-id-type="pmid">9176387</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Migliore</surname><given-names>L.</given-names></name><name><surname>Boni</surname><given-names>G.</given-names></name><name><surname>Bernardini</surname><given-names>R.</given-names></name><name><surname>Trippi</surname><given-names>F.</given-names></name><name><surname>Colognato</surname><given-names>R.</given-names></name><name><surname>Fontana</surname><given-names>I.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Susceptibility to chromosome malsegregation in lymphocytes of women who had a Down syndrome child in young age</article-title>. <source/>Neurobiol Aging
<volume>27</volume> (<issue>5</issue>), <fpage>710</fpage>–<lpage>716</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2005.03.025</pub-id>
<pub-id pub-id-type="pmid">16005550</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Migliore</surname><given-names>L.</given-names></name><name><surname>Botto</surname><given-names>N.</given-names></name><name><surname>Scarpato</surname><given-names>R.</given-names></name><name><surname>Petrozzi</surname><given-names>L.</given-names></name><name><surname>Cipriani</surname><given-names>G.</given-names></name><name><surname>Bonuccelli</surname><given-names>U.</given-names></name></person-group> (<year>1999</year>). <article-title>Preferential occurrence of chromosome 21 malsegregation in peripheral blood lymphocytes of Alzheimer disease patients</article-title>. <source/>Cytogenet Cell Genet.
<volume>87</volume> (<issue>1-2</issue>), <fpage>41</fpage>–<lpage>46</lpage>. 15389<pub-id pub-id-type="pmid">10640809</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Migliore</surname><given-names>L.</given-names></name><name><surname>Testa</surname><given-names>A.</given-names></name><name><surname>Scarpato</surname><given-names>R.</given-names></name><name><surname>Pavese</surname><given-names>N.</given-names></name><name><surname>Petrozzi</surname><given-names>L.</given-names></name><name><surname>Bonuccelli</surname><given-names>U.</given-names></name></person-group> (<year>1997</year>). <article-title>Spontaneous and induced aneuploidy in peripheral blood lymphocytes of patients with Alzheimer’s disease</article-title>. <source/>Hum. Genet.
<volume>101</volume> (<issue>3</issue>), <fpage>299</fpage>–<lpage>305</lpage>. <pub-id pub-id-type="doi">10.1007/s004390050632</pub-id>
<pub-id pub-id-type="pmid">9439658</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mkrtchyan</surname><given-names>H.</given-names></name><name><surname>Gross</surname><given-names>M.</given-names></name><name><surname>Hinreiner</surname><given-names>S.</given-names></name><name><surname>Polytiko</surname><given-names>A.</given-names></name><name><surname>Manvelyan</surname><given-names>M.</given-names></name><name><surname>Mrasek</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>The human genome puzzle - the role of copy number variation in somatic mosaicism</article-title>. <source/>Curr. Genomics
<volume>11</volume> (<issue>6</issue>), <fpage>426</fpage>–<lpage>431</lpage>. <pub-id pub-id-type="doi">10.2174/138920210793176047</pub-id>
<pub-id pub-id-type="pmid">21358987</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mokrani-Benhelli</surname><given-names>H.</given-names></name><name><surname>Gaillard</surname><given-names>L.</given-names></name><name><surname>Biasutto</surname><given-names>P.</given-names></name><name><surname>Le Guen</surname><given-names>T.</given-names></name><name><surname>Touzot</surname><given-names>F.</given-names></name><name><surname>Vasquez</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Primary microcephaly, impaired DNA replication, and genomic instability caused by compound heterozygous ATR mutations</article-title>. <source/>Hum Mutat
<volume>34</volume> (<issue>2</issue>), <fpage>374</fpage>–<lpage>384</lpage>. <pub-id pub-id-type="doi">10.1002/humu.22245</pub-id>
<pub-id pub-id-type="pmid">23111928</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mosch</surname><given-names>B.</given-names></name><name><surname>Morawski</surname><given-names>M.</given-names></name><name><surname>Mittag</surname><given-names>A.</given-names></name><name><surname>Lenz</surname><given-names>D.</given-names></name><name><surname>Tarnok</surname><given-names>A.</given-names></name><name><surname>Arendt</surname><given-names>T.</given-names></name></person-group> (<year>2007</year>). <article-title>Aneuploidy and DNA replication in the normal human brain and Alzheimer’s disease</article-title>. <source/>J. Neurosci.
<volume>27</volume> (<issue>26</issue>), <fpage>6859</fpage>–<lpage>6867</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0379-07.2007</pub-id>
<pub-id pub-id-type="pmid">17596434</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mu</surname><given-names>Y.</given-names></name><name><surname>Gage</surname><given-names>F. H.</given-names></name></person-group> (<year>2011</year>). <article-title>Adult hippocampal neurogenesis and its role in Alzheimer’s disease</article-title>. <source/>Mol. Neurodegener
<volume>6</volume>, <fpage>85</fpage>. <pub-id pub-id-type="doi">10.1186/1750-1326-6-85</pub-id>
<pub-id pub-id-type="pmid">22192775</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Murga</surname><given-names>M.</given-names></name><name><surname>Bunting</surname><given-names>S.</given-names></name><name><surname>Montana</surname><given-names>M. F.</given-names></name><name><surname>Soria</surname><given-names>R.</given-names></name><name><surname>Mulero</surname><given-names>F.</given-names></name><name><surname>Canamero</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>A mouse model of ATR-Seckel shows embryonic replicative stress and accelerated aging</article-title>. <source/>Nat. Genet.
<volume>41</volume> (<issue>8</issue>), <fpage>891</fpage>–<lpage>898</lpage>. <pub-id pub-id-type="doi">10.1038/ng.420</pub-id>
<pub-id pub-id-type="pmid">19620979</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nalepa</surname><given-names>G.</given-names></name><name><surname>Enzor</surname><given-names>R.</given-names></name><name><surname>Sun</surname><given-names>Z.</given-names></name><name><surname>Marchal</surname><given-names>C.</given-names></name><name><surname>Park</surname><given-names>S. J.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Fanconi anemia signaling network regulates the spindle assembly checkpoint</article-title>. <source/>J. Clin. Invest.
<volume>123</volume> (<issue>9</issue>), <fpage>3839</fpage>–<lpage>3847</lpage>. <pub-id pub-id-type="doi">10.1172/JCI67364</pub-id>
<pub-id pub-id-type="pmid">23934222</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nieznanska</surname><given-names>H.</given-names></name><name><surname>Dudek</surname><given-names>E.</given-names></name><name><surname>Zajkowski</surname><given-names>T.</given-names></name><name><surname>Szczesna</surname><given-names>E.</given-names></name><name><surname>Kasprzak</surname><given-names>A. A.</given-names></name><name><surname>Nieznanski</surname><given-names>K.</given-names></name></person-group> (<year>2012</year>). <article-title>Prion protein impairs kinesin-driven transport</article-title>. <source/>Biochem. Biophys Res. Commun.
<volume>425</volume> (<issue>4</issue>), <fpage>788</fpage>–<lpage>793</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2012.07.153</pub-id>
<pub-id pub-id-type="pmid">22885185</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nizzari</surname><given-names>M.</given-names></name><name><surname>Venezia</surname><given-names>V.</given-names></name><name><surname>Bianchini</surname><given-names>P.</given-names></name><name><surname>Caorsi</surname><given-names>V.</given-names></name><name><surname>Diaspro</surname><given-names>A.</given-names></name><name><surname>Repetto</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2007</year>a). <article-title>Amyloid precursor protein and Presenilin 1 interaction studied by FRET in human H4 cells</article-title>. <source/>Ann N Y Acad. Sci.
<volume>1096</volume>, <fpage>249</fpage>–<lpage>257</lpage>. <pub-id pub-id-type="doi">10.1196/annals.1397.091</pub-id>
<pub-id pub-id-type="pmid">17405936</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nizzari</surname><given-names>M.</given-names></name><name><surname>Venezia</surname><given-names>V.</given-names></name><name><surname>Repetto</surname><given-names>E.</given-names></name><name><surname>Caorsi</surname><given-names>V.</given-names></name><name><surname>Magrassi</surname><given-names>R.</given-names></name><name><surname>Gagliani</surname><given-names>M. C.</given-names></name><etal></etal></person-group> (<year>2007</year>b). <article-title>Amyloid precursor protein and Presenilin1 interact with the adaptor GRB2 and modulate ERK 1,2 signaling</article-title>. <source/>J. Biol. Chem.
<volume>282</volume> (<issue>18</issue>), <fpage>13833</fpage>–<lpage>13844</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M610146200</pub-id>
<pub-id pub-id-type="pmid">17314098</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ohashi</surname><given-names>A.</given-names></name><name><surname>Ohori</surname><given-names>M.</given-names></name><name><surname>Iwai</surname><given-names>K.</given-names></name><name><surname>Nakayama</surname><given-names>Y.</given-names></name><name><surname>Nambu</surname><given-names>T.</given-names></name><name><surname>Morishita</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Aneuploidy generates proteotoxic stress and DNA damage concurrently with p53-mediated post-mitotic apoptosis in SAC-impaired cells</article-title>. <source/>Nat. Commun.
<volume>6</volume>, <fpage>7668</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms8668</pub-id>
<pub-id pub-id-type="pmid">26144554</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Oromendia</surname><given-names>A. B.</given-names></name><name><surname>Amon</surname><given-names>A.</given-names></name></person-group> (<year>2014</year>). <article-title>Aneuploidy: implications for protein homeostasis and disease</article-title>. <source/>Dis. Model Mech.
<volume>7</volume> (<issue>1</issue>), <fpage>15</fpage>–<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1242/dmm.013391</pub-id>
<pub-id pub-id-type="pmid">24396150</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Oromendia</surname><given-names>A. B.</given-names></name><name><surname>Dodgson</surname><given-names>S. E.</given-names></name><name><surname>Amon</surname><given-names>A.</given-names></name></person-group> (<year>2012</year>). <article-title>Aneuploidy causes proteotoxic stress in yeast</article-title>. <source/>Genes Dev.
<volume>26</volume> (<issue>24</issue>), <fpage>2696</fpage>–<lpage>2708</lpage>. <pub-id pub-id-type="doi">10.1101/gad.207407.112</pub-id>
<pub-id pub-id-type="pmid">23222101</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Petersen</surname><given-names>M. B.</given-names></name><name><surname>Karadima</surname><given-names>G.</given-names></name><name><surname>Samaritaki</surname><given-names>M.</given-names></name><name><surname>Avramopoulos</surname><given-names>D.</given-names></name><name><surname>Vassilopoulos</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2000</year>). <article-title>Association between presenilin-1 polymorphism and maternal meiosis II errors in Down syndrome</article-title>. <source/>Am. J. Med. Genet.
<volume>93</volume> (<issue>5</issue>), <fpage>366</fpage>–<lpage>372</lpage>. <pub-id pub-id-type="doi">10.1002/1096-8628(20000828)93:5&lt;366::aid-ajmg5&gt;3.0.co;2-g</pub-id>
<pub-id pub-id-type="pmid">10951459</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Podvin</surname><given-names>S.</given-names></name><name><surname>Reardon</surname><given-names>H. T.</given-names></name><name><surname>Yin</surname><given-names>K.</given-names></name><name><surname>Mosier</surname><given-names>C.</given-names></name><name><surname>Hook</surname><given-names>V.</given-names></name></person-group> (<year>2019</year>). <article-title>Multiple clinical features of Huntington’s disease correlate with mutant HTT gene CAG repeat lengths and neurodegeneration</article-title>. <source/>J. Neurol.
<volume>266</volume> (<issue>3</issue>), <fpage>551</fpage>–<lpage>564</lpage>. <pub-id pub-id-type="doi">10.1007/s00415-018-8940-6</pub-id>
<pub-id pub-id-type="pmid">29956026</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Potter</surname><given-names>H.</given-names></name></person-group> (<year>1991</year>). <article-title>Review and hypothesis: Alzheimer disease and Down syndrome–chromosome 21 nondisjunction may underlie both disorders</article-title>. <source/>Am. J. Hum. Genet.
<volume>48</volume> (<issue>6</issue>), <fpage>1192</fpage>–<lpage>1200</lpage>.<pub-id pub-id-type="pmid">1827946</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Potter</surname><given-names>H.</given-names></name><name><surname>Granic</surname><given-names>A.</given-names></name><name><surname>Caneus</surname><given-names>J.</given-names></name></person-group> (<year>2016</year>). <article-title>Role of Trisomy 21 Mosaicism in Sporadic and Familial Alzheimer’s Disease</article-title>. <source/>Curr. Alzheimer Res.
<volume>13</volume> (<issue>1</issue>), <fpage>7</fpage>–<lpage>17</lpage>. <pub-id pub-id-type="doi">10.2174/156720501301151207100616</pub-id>
<pub-id pub-id-type="pmid">26651340</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Potter</surname><given-names>H.</given-names></name><name><surname>Ma</surname><given-names>J.</given-names></name><name><surname>Das</surname><given-names>S.</given-names></name><name><surname>Geller</surname><given-names>L. N.</given-names></name><name><surname>Benjamin</surname><given-names>M.</given-names></name><name><surname>Kayyali</surname><given-names>U. S.</given-names></name><etal></etal></person-group>, (<year>1995</year>). “<article-title>Beyond β-protein: New steps in the pathogenic pathway to Alzheimer’s disease</article-title>,” in <source/>Research Advances in Alzheimer’s Disease and Related Disorders. Eds. <person-group person-group-type="editor"><name><surname>Iqbal</surname><given-names>K.</given-names></name><name><surname>Mortimer</surname><given-names>J. A.</given-names></name><name><surname>Winblad</surname><given-names>B.</given-names></name><name><surname>Wisniewski</surname><given-names>H. M.</given-names></name></person-group> (<publisher-loc>New York</publisher-loc>: <publisher-name>John Wiley and Sons Ltd.</publisher-name>), <fpage>643</fpage>–<lpage>654</lpage>.</mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Potter</surname><given-names>H.</given-names></name><name><surname>Wisniewski</surname><given-names>T.</given-names></name></person-group> (<year>2012</year>). <article-title>Apolipoprotein e: essential catalyst of the Alzheimer amyloid cascade</article-title>. <source/>Int. J. Alzheimers Dis.
<volume>2012</volume>, <fpage>489428</fpage>. <pub-id pub-id-type="doi">10.1155/2012/489428</pub-id>
<pub-id pub-id-type="pmid">22844635</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Prasher</surname><given-names>V. P.</given-names></name><name><surname>Farrer</surname><given-names>M. J.</given-names></name><name><surname>Kessling</surname><given-names>A. M.</given-names></name><name><surname>Fisher</surname><given-names>E. M.</given-names></name><name><surname>West</surname><given-names>R. J.</given-names></name><name><surname>Barber</surname><given-names>P. C.</given-names></name><etal></etal></person-group> (<year>1998</year>). <article-title>Molecular mapping of Alzheimer-type dementia in Down’s syndrome</article-title>. <source/>Ann Neurol
<volume>43</volume> (<issue>3</issue>), <fpage>380</fpage>–<lpage>383</lpage>. <pub-id pub-id-type="doi">10.1002/ana.410430316</pub-id>
<pub-id pub-id-type="pmid">9506555</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Quek</surname><given-names>H.</given-names></name><name><surname>Luff</surname><given-names>J.</given-names></name><name><surname>Cheung</surname><given-names>K.</given-names></name><name><surname>Kozlov</surname><given-names>S.</given-names></name><name><surname>Gatei</surname><given-names>M.</given-names></name><name><surname>Lee</surname><given-names>C. S.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>A rat model of ataxia-telangiectasia: evidence for a neurodegenerative phenotype</article-title>. <source/>Hum. Mol. Genet.
<volume>26</volume> (<issue>1</issue>), <fpage>109</fpage>–<lpage>123</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddw371</pub-id>
<pub-id pub-id-type="pmid">28007901</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rademakers</surname><given-names>R.</given-names></name><name><surname>Neumann</surname><given-names>M.</given-names></name><name><surname>Mackenzie</surname><given-names>I. R.</given-names></name></person-group> (<year>2012</year>). <article-title>Advances in understanding the molecular basis of frontotemporal dementia</article-title>. <source/>Nat. Rev. Neurol.
<volume>8</volume> (<issue>8</issue>), <fpage>423</fpage>–<lpage>434</lpage>. <pub-id pub-id-type="doi">10.1038/nrneurol.2012.117</pub-id>
<pub-id pub-id-type="pmid">22732773</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rajendran</surname><given-names>R. S.</given-names></name><name><surname>Wellbrock</surname><given-names>U. M.</given-names></name><name><surname>Zupanc</surname><given-names>G. K.</given-names></name></person-group> (<year>2008</year>). <article-title>Apoptotic cell death, long-term persistence, and neuronal differentiation of aneuploid cells generated in the adult brain of teleost fish</article-title>. <source/>Dev Neurobiol
<volume>68</volume> (<issue>10</issue>), <fpage>1257</fpage>–<lpage>1268</lpage>. <pub-id pub-id-type="doi">10.1002/dneu.20656</pub-id>
<pub-id pub-id-type="pmid">18563701</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rao</surname><given-names>C. V.</given-names></name><name><surname>Farooqui</surname><given-names>M.</given-names></name><name><surname>Asch</surname><given-names>A. S.</given-names></name><name><surname>Yamada</surname><given-names>H. Y.</given-names></name></person-group> (<year>2018</year>a). <article-title>Critical role of mitosis in spontaneous late-onset Alzheimer’s disease; from a Shugoshin 1 cohesinopathy mouse model</article-title>. <source/>Cell Cycle
<volume>17</volume> (<issue>19-20</issue>), <fpage>2321</fpage>–<lpage>2334</lpage>. <pub-id pub-id-type="doi">10.1080/15384101.2018.1515554</pub-id>
<pub-id pub-id-type="pmid">30231670</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rao</surname><given-names>C. V.</given-names></name><name><surname>Farooqui</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Asch</surname><given-names>A. S.</given-names></name><name><surname>Yamada</surname><given-names>H. Y.</given-names></name></person-group> (<year>2018</year>b). <article-title>Spontaneous development of Alzheimer’s disease-associated brain pathology in a Shugoshin-1 mouse cohesinopathy model</article-title>. <source/>Aging Cell
<volume>17</volume> (<issue>4</issue>), <fpage>e12797</fpage>. <pub-id pub-id-type="doi">10.1111/acel.12797</pub-id>
<pub-id pub-id-type="pmid">29943428</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rodriguez-Manotas</surname><given-names>M.</given-names></name><name><surname>Amorin-Diaz</surname><given-names>M.</given-names></name><name><surname>Canizares-Hernandez</surname><given-names>F.</given-names></name><name><surname>Ruiz-Espejo</surname><given-names>F.</given-names></name><name><surname>Martinez-Vidal</surname><given-names>S.</given-names></name><name><surname>Gonzalez-Sarmiento</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Association study and meta-analysis of Alzheimer’s disease risk and presenilin-1 intronic polymorphism</article-title>. <source/>Brain Res.
<volume>1170</volume>, <fpage>119</fpage>–<lpage>128</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2007.07.032</pub-id>
<pub-id pub-id-type="pmid">17719017</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rohrback</surname><given-names>S.</given-names></name><name><surname>Siddoway</surname><given-names>B.</given-names></name><name><surname>Liu</surname><given-names>C. S.</given-names></name><name><surname>Chun</surname><given-names>J.</given-names></name></person-group> (<year>2018</year>). <article-title>Genomic mosaicism in the developing and adult brain</article-title>. <source/>Dev. Neurobiol.
<volume>78</volume> (<issue>11</issue>), <fpage>1026</fpage>–<lpage>1048</lpage>. <pub-id pub-id-type="doi">10.1002/dneu.22626</pub-id>
<pub-id pub-id-type="pmid">30027562</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rossi</surname><given-names>G.</given-names></name><name><surname>Conconi</surname><given-names>D.</given-names></name><name><surname>Panzeri</surname><given-names>E.</given-names></name><name><surname>Paoletta</surname><given-names>L.</given-names></name><name><surname>Piccoli</surname><given-names>E.</given-names></name><name><surname>Ferretti</surname><given-names>M. G.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Mutations in MAPT give rise to aneuploidy in animal models of tauopathy</article-title>. <source/>Neurogenetics
<volume>15</volume> (<issue>1</issue>), <fpage>31</fpage>–<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1007/s10048-013-0380-y</pub-id>
<pub-id pub-id-type="pmid">24218087</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rossi</surname><given-names>G.</given-names></name><name><surname>Conconi</surname><given-names>D.</given-names></name><name><surname>Panzeri</surname><given-names>E.</given-names></name><name><surname>Redaelli</surname><given-names>S.</given-names></name><name><surname>Piccoli</surname><given-names>E.</given-names></name><name><surname>Paoletta</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Mutations in MAPT gene cause chromosome instability and introduce copy number variations widely in the genome</article-title>. <source/>J. Alzheimers Dis.
<volume>33</volume> (<issue>4</issue>), <fpage>969</fpage>–<lpage>982</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-2012-121633</pub-id>
<pub-id pub-id-type="pmid">23047372</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rossi</surname><given-names>G.</given-names></name><name><surname>Dalpra</surname><given-names>L.</given-names></name><name><surname>Crosti</surname><given-names>F.</given-names></name><name><surname>Lissoni</surname><given-names>S.</given-names></name><name><surname>Sciacca</surname><given-names>F. L.</given-names></name><etal></etal></person-group>, (<year>2008</year>). <article-title>A new function of microtubule-associated protein tau: involvement in chromosome stability</article-title>. <source/>Cell Cycle
<volume>7</volume> (<issue>12</issue>), <fpage>1788</fpage>–<lpage>1794</lpage>. <pub-id pub-id-type="doi">10.4161/cc.7.12.6012</pub-id>
<pub-id pub-id-type="pmid">18583940</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rovelet-Lecrux</surname><given-names>A.</given-names></name><name><surname>Hannequin</surname><given-names>D.</given-names></name><name><surname>Raux</surname><given-names>G.</given-names></name><name><surname>Le Meur</surname><given-names>N.</given-names></name><name><surname>Laquerriere</surname><given-names>A.</given-names></name><name><surname>Vital</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy</article-title>. <source/>Nat. Genet.
<volume>38</volume> (<issue>1</issue>), <fpage>24</fpage>–<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1038/ng1718</pub-id>
<pub-id pub-id-type="pmid">16369530</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sakamoto</surname><given-names>M.</given-names></name><name><surname>Ieki</surname><given-names>N.</given-names></name><name><surname>Miyoshi</surname><given-names>G.</given-names></name><name><surname>Mochimaru</surname><given-names>D.</given-names></name><name><surname>Miyachi</surname><given-names>H.</given-names></name><name><surname>Imura</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Continuous postnatal neurogenesis contributes to formation of the olfactory bulb neural circuits and flexible olfactory associative learning</article-title>. <source/>J. Neurosci.
<volume>34</volume> (<issue>17</issue>), <fpage>5788</fpage>–<lpage>5799</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0674-14.2014</pub-id>
<pub-id pub-id-type="pmid">24760839</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Saldivar</surname><given-names>J. C.</given-names></name><name><surname>Cimprich</surname><given-names>K. A.</given-names></name></person-group> (<year>2018</year>). <article-title>A new mitotic activity comes into focus</article-title>. <source/>Science
<volume>359</volume> (<issue>6371</issue>), <fpage>30</fpage>–<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1126/science.aar4799</pub-id>
<pub-id pub-id-type="pmid">29302000</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sathasivam</surname><given-names>K.</given-names></name><name><surname>Woodman</surname><given-names>B.</given-names></name><name><surname>Mahal</surname><given-names>A.</given-names></name><name><surname>Bertaux</surname><given-names>F.</given-names></name><name><surname>Wanker</surname><given-names>E. E.</given-names></name><name><surname>Shima</surname><given-names>D. T.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>Centrosome disorganization in fibroblast cultures derived from R6/2 Huntington’s disease (HD) transgenic mice and HD patients</article-title>. <source/>Hum. Mol. Genet.
<volume>10</volume> (<issue>21</issue>), <fpage>2425</fpage>–<lpage>2435</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/10.21.2425</pub-id>
<pub-id pub-id-type="pmid">11689489</pub-id></mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schupf</surname><given-names>N.</given-names></name><name><surname>Kapell</surname><given-names>D.</given-names></name><name><surname>Lee</surname><given-names>J. H.</given-names></name><name><surname>Ottman</surname><given-names>R.</given-names></name><name><surname>Mayeux</surname><given-names>R.</given-names></name></person-group> (<year>1994</year>). <article-title>Increased risk of Alzheimer’s disease in mothers of adults with Down’s syndrome</article-title>. <source/>Lancet
<volume>344</volume> (<issue>8919</issue>), <fpage>353</fpage>–<lpage>356</lpage>. <pub-id pub-id-type="doi">10.1016/s0140-6736(94)91398-6</pub-id>
<pub-id pub-id-type="pmid">7914304</pub-id></mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Seward</surname><given-names>M. E.</given-names></name><name><surname>Swanson</surname><given-names>E.</given-names></name><name><surname>Norambuena</surname><given-names>A.</given-names></name><name><surname>Reimann</surname><given-names>A.</given-names></name><name><surname>Cochran</surname><given-names>J. N.</given-names></name><name><surname>Li</surname><given-names>R.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Amyloid-beta signals through tau to drive ectopic neuronal cell cycle re-entry in Alzheimer’s disease</article-title>. <source/>J. Cell Sci.
<volume>126</volume> (<issue>Pt 5</issue>), <fpage>1278</fpage>–<lpage>1286</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.1125880</pub-id>
<pub-id pub-id-type="pmid">23345405</pub-id></mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shen</surname><given-names>K. C.</given-names></name><name><surname>Heng</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Lu</surname><given-names>S.</given-names></name><name><surname>Liu</surname><given-names>G.</given-names></name><name><surname>Deng</surname><given-names>C. X.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>ATM and p21 cooperate to suppress aneuploidy and subsequent tumor development</article-title>. <source/>Cancer Res.
<volume>65</volume> (<issue>19</issue>), <fpage>8747</fpage>–<lpage>8753</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-05-1471</pub-id>
<pub-id pub-id-type="pmid">16204044</pub-id></mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shimada</surname><given-names>M.</given-names></name><name><surname>Kobayashi</surname><given-names>J.</given-names></name><name><surname>Hirayama</surname><given-names>R.</given-names></name><name><surname>Komatsu</surname><given-names>K.</given-names></name></person-group> (<year>2010</year>). <article-title>Differential role of repair proteins, BRCA1/NBS1 and Ku70/DNA-PKcs, in radiation-induced centrosome overduplication</article-title>. <source/>Cancer Sci.
<volume>101</volume> (<issue>12</issue>), <fpage>2531</fpage>–<lpage>2537</lpage>. <pub-id pub-id-type="doi">10.1111/j.1349-7006.2010.01702.x</pub-id>
<pub-id pub-id-type="pmid">20825415</pub-id></mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shimada</surname><given-names>M.</given-names></name><name><surname>Sagae</surname><given-names>R.</given-names></name><name><surname>Kobayashi</surname><given-names>J.</given-names></name><name><surname>Habu</surname><given-names>T.</given-names></name><name><surname>Komatsu</surname><given-names>K.</given-names></name></person-group> (<year>2009</year>). <article-title>Inactivation of the Nijmegen breakage syndrome gene leads to excess centrosome duplication <italic>via the</italic> ATR/BRCA1 pathway</article-title>. <source/>Cancer Res.
<volume>69</volume> (<issue>5</issue>), <fpage>1768</fpage>–<lpage>1775</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-08-3016</pub-id>
<pub-id pub-id-type="pmid">19244116</pub-id></mixed-citation>
</ref>
<ref id="B106">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sleegers</surname><given-names>K.</given-names></name><name><surname>Brouwers</surname><given-names>N.</given-names></name><name><surname>Gijselinck</surname><given-names>I.</given-names></name><name><surname>Theuns</surname><given-names>J.</given-names></name><name><surname>Goossens</surname><given-names>D.</given-names></name><name><surname>Wauters</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>APP duplication is sufficient to cause early onset Alzheimer’s dementia with cerebral amyloid angiopathy</article-title>. <source/>Brain
<volume>129</volume> (<issue>Pt 11</issue>), <fpage>2977</fpage>–<lpage>2983</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awl203</pub-id>
<pub-id pub-id-type="pmid">16921174</pub-id></mixed-citation>
</ref>
<ref id="B107">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sorrells</surname><given-names>S. F.</given-names></name><name><surname>Paredes</surname><given-names>M. F.</given-names></name><name><surname>Cebrian-Silla</surname><given-names>A.</given-names></name><name><surname>Sandoval</surname><given-names>K.</given-names></name><name><surname>Qi</surname><given-names>D.</given-names></name><name><surname>Kelley</surname><given-names>K. W.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>Human hippocampal neurogenesis drops sharply in children to undetectable levels in adults</article-title>. <source/>Nature
<volume>555</volume> (<issue>7696</issue>), <fpage>377</fpage>–<lpage>381</lpage>. <pub-id pub-id-type="doi">10.1038/nature25975</pub-id>
<pub-id pub-id-type="pmid">29513649</pub-id></mixed-citation>
</ref>
<ref id="B108">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Spalding</surname><given-names>K. L.</given-names></name><name><surname>Bergmann</surname><given-names>O.</given-names></name><name><surname>Alkass</surname><given-names>K.</given-names></name><name><surname>Bernard</surname><given-names>S.</given-names></name><name><surname>Salehpour</surname><given-names>M.</given-names></name><name><surname>Huttner</surname><given-names>H. B.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Dynamics of hippocampal neurogenesis in adult humans</article-title>. <source/>Cell
<volume>153</volume> (<issue>6</issue>), <fpage>1219</fpage>–<lpage>1227</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2013.05.002</pub-id>
<pub-id pub-id-type="pmid">23746839</pub-id></mixed-citation>
</ref>
<ref id="B109">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Spring</surname><given-names>K.</given-names></name><name><surname>Ahangari</surname><given-names>F.</given-names></name><name><surname>Scott</surname><given-names>S. P.</given-names></name><name><surname>Waring</surname><given-names>P.</given-names></name><name><surname>Purdie</surname><given-names>D. M.</given-names></name><name><surname>Chen</surname><given-names>P. C.</given-names></name><etal></etal></person-group> (<year>2002</year>). <article-title>Mice heterozygous for mutation in Atm, the gene involved in ataxia-telangiectasia, have heightened susceptibility to cancer</article-title>. <source/>Nat. Genet.
<volume>32</volume> (<issue>1</issue>), <fpage>185</fpage>–<lpage>190</lpage>. <pub-id pub-id-type="doi">10.1038/ng958</pub-id>
<pub-id pub-id-type="pmid">12195425</pub-id></mixed-citation>
</ref>
<ref id="B110">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stiff</surname><given-names>T.</given-names></name><name><surname>Casar Tena</surname><given-names>T.</given-names></name><name><surname>O’Driscoll</surname><given-names>M.</given-names></name><name><surname>Jeggo</surname><given-names>P. A.</given-names></name><name><surname>Philipp</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>ATR promotes cilia signalling: links to developmental impacts</article-title>. <source/>Hum Mol. Genet.
<volume>25</volume> (<issue>8</issue>), <fpage>1574</fpage>–<lpage>1587</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddw034</pub-id>
<pub-id pub-id-type="pmid">26908596</pub-id></mixed-citation>
</ref>
<ref id="B111">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tatzelt</surname><given-names>J.</given-names></name><name><surname>Maeda</surname><given-names>N.</given-names></name><name><surname>Pekny</surname><given-names>M.</given-names></name><name><surname>Yang</surname><given-names>S. L.</given-names></name><name><surname>Betsholtz</surname><given-names>C.</given-names></name><name><surname>Eliasson</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>1996</year>). <article-title>Scrapie in mice deficient in apolipoprotein E or glial fibrillary acidic protein</article-title>. <source/>Neurology
<volume>47</volume> (<issue>2</issue>), <fpage>449</fpage>–<lpage>453</lpage>. <pub-id pub-id-type="doi">10.1212/wnl.47.2.449</pub-id>
<pub-id pub-id-type="pmid">8757019</pub-id></mixed-citation>
</ref>
<ref id="B112">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Thomas</surname><given-names>P.</given-names></name><name><surname>Fenech</surname><given-names>M.</given-names></name></person-group> (<year>2008</year>). <article-title>Chromosome 17 and 21 aneuploidy in buccal cells is increased with ageing and in Alzheimer’s disease</article-title>. <source/>Mutagenesis
<volume>23</volume> (<issue>1</issue>), <fpage>57</fpage>–<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1093/mutage/gem044</pub-id>
<pub-id pub-id-type="pmid">18048581</pub-id></mixed-citation>
</ref>
<ref id="B113">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Trippi</surname><given-names>F.</given-names></name><name><surname>Botto</surname><given-names>N.</given-names></name><name><surname>Scarpato</surname><given-names>R.</given-names></name><name><surname>Petrozzi</surname><given-names>L.</given-names></name><name><surname>Bonuccelli</surname><given-names>U.</given-names></name><name><surname>Latorraca</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>Spontaneous and induced chromosome damage in somatic cells of sporadic and familial Alzheimer’s disease patients</article-title>. <source/>Mutagenesis
<volume>16</volume> (<issue>4</issue>), <fpage>323</fpage>–<lpage>327</lpage>. <pub-id pub-id-type="doi">10.1093/mutage/16.4.323</pub-id>
<pub-id pub-id-type="pmid">11420400</pub-id></mixed-citation>
</ref>
<ref id="B114">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vessey</surname><given-names>C. J.</given-names></name><name><surname>Norbury</surname><given-names>C. J.</given-names></name><name><surname>Hickson</surname><given-names>I. D.</given-names></name></person-group> (<year>1999</year>). <article-title>Genetic disorders associated with cancer predisposition and genomic instability</article-title>. <source/>Prog. Nucleic Acid Res. Mol. Biol.
<volume>63</volume>, <fpage>189</fpage>–<lpage>221</lpage>.<pub-id pub-id-type="pmid">10506832</pub-id></mixed-citation>
</ref>
<ref id="B115">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vincent</surname><given-names>I.</given-names></name><name><surname>Jicha</surname><given-names>G.</given-names></name><name><surname>Rosado</surname><given-names>M.</given-names></name><name><surname>Dickson</surname><given-names>D. W.</given-names></name></person-group> (<year>1997</year>). <article-title>Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer’s disease brain</article-title>. <source/>J. Neurosci.
<volume>17</volume> (<issue>10</issue>), <fpage>3588</fpage>–<lpage>3598</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.132.3.413</pub-id>
<pub-id pub-id-type="pmid">9133382</pub-id></mixed-citation>
</ref>
<ref id="B116">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vincent</surname><given-names>I.</given-names></name><name><surname>Rosado</surname><given-names>M.</given-names></name><name><surname>Davies</surname><given-names>P.</given-names></name></person-group> (<year>1996</year>). <article-title>Mitotic mechanisms in Alzheimer’s disease</article-title>? <source/>J. Cell Biol.
<volume>132</volume> (<issue>3</issue>), <fpage>413</fpage>–<lpage>425</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.132.3.413</pub-id>
<pub-id pub-id-type="pmid">8636218</pub-id></mixed-citation>
</ref>
<ref id="B117">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wisniewski</surname><given-names>K. E.</given-names></name><name><surname>Wisniewski</surname><given-names>H. M.</given-names></name><name><surname>Wen</surname><given-names>G. Y.</given-names></name></person-group> (<year>1985</year>). <article-title>Occurrence of neuropathological changes and dementia of Alzheimer’s disease in Down’s syndrome</article-title>. <source/>Ann. Neurol.
<volume>17</volume> (<issue>3</issue>), <fpage>278</fpage>–<lpage>282</lpage>. <pub-id pub-id-type="doi">10.1002/ana.410170310</pub-id>
<pub-id pub-id-type="pmid">3158266</pub-id></mixed-citation>
</ref>
<ref id="B118">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wright</surname><given-names>J. A.</given-names></name><name><surname>Keegan</surname><given-names>K. S.</given-names></name><name><surname>Herendeen</surname><given-names>D. R.</given-names></name><name><surname>Bentley</surname><given-names>N. J.</given-names></name><name><surname>Carr</surname><given-names>A. M.</given-names></name><etal></etal></person-group>, (<year>1998</year>). <article-title>Protein kinase mutants of human ATR increase sensitivity to UV and ionizing radiation and abrogate cell cycle checkpoint control</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>95</volume> (<issue>13</issue>), <fpage>7445</fpage>–<lpage>7450</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.95.13.7445</pub-id>
<pub-id pub-id-type="pmid">9636169</pub-id></mixed-citation>
</ref>
<ref id="B119">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yamada</surname><given-names>H. Y.</given-names></name><name><surname>Yao</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Huang</surname><given-names>Y.</given-names></name><name><surname>Dai</surname><given-names>W.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>Haploinsufficiency of SGO1 results in deregulated centrosome dynamics, enhanced chromosomal instability and colon tumorigenesis</article-title>. <source/>Cell Cycle
<volume>11</volume> (<issue>3</issue>), <fpage>479</fpage>–<lpage>488</lpage>. <pub-id pub-id-type="doi">10.4161/cc.11.3.18994</pub-id>
<pub-id pub-id-type="pmid">22262168</pub-id></mixed-citation>
</ref>
<ref id="B120">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Geldmacher</surname><given-names>D. S.</given-names></name><name><surname>Herrup</surname><given-names>K.</given-names></name></person-group> (<year>2001</year>). <article-title>DNA replication precedes neuronal cell death in Alzheimer’s disease</article-title>. <source/>J. Neurosci.
<volume>21</volume> (<issue>8</issue>), <fpage>2661</fpage>–<lpage>2668</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.21-08-02661.2001</pub-id>
<pub-id pub-id-type="pmid">11306619</pub-id></mixed-citation>
</ref>
<ref id="B121">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Shepherd</surname><given-names>C.</given-names></name><name><surname>Halliday</surname><given-names>G.</given-names></name></person-group> (<year>2015</year>). <article-title>Aneuploidy in Lewy body diseases</article-title>. <source/>Neurobiol Aging
<volume>36</volume> (<issue>3</issue>), <fpage>1253</fpage>–<lpage>1260</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2014.12.016</pub-id>
<pub-id pub-id-type="pmid">25595497</pub-id></mixed-citation>
</ref>
<ref id="B122">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yazinski</surname><given-names>S. A.</given-names></name><name><surname>Zou</surname><given-names>L.</given-names></name></person-group> (<year>2016</year>). <article-title>Functions, Regulation, and Therapeutic Implications of the ATR Checkpoint Pathway</article-title>. <source/>Annu. Rev. Genet.
<volume>50</volume>, <fpage>155</fpage>–<lpage>173</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-genet-121415-121658</pub-id>
<pub-id pub-id-type="pmid">27617969</pub-id></mixed-citation>
</ref>
<ref id="B123">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Young-Pearse</surname><given-names>T. L.</given-names></name><name><surname>Suth</surname><given-names>S.</given-names></name><name><surname>Luth</surname><given-names>E. S.</given-names></name><name><surname>Sawa</surname><given-names>A.</given-names></name><name><surname>Selkoe</surname><given-names>D. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Biochemical and functional interaction of disrupted-in-schizophrenia 1 and amyloid precursor protein regulates neuronal migration during mammalian cortical development</article-title>. <source/>J. Neurosci.
<volume>30</volume> (<issue>31</issue>), <fpage>10431</fpage>–<lpage>10440</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1445-10.2010</pub-id>
<pub-id pub-id-type="pmid">20685985</pub-id></mixed-citation>
</ref>
<ref id="B124">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yurov</surname><given-names>Y. B.</given-names></name><name><surname>Vorsanova</surname><given-names>S. G.</given-names></name><name><surname>Iourov</surname><given-names>I. Y.</given-names></name></person-group> (<year>2009</year>). <article-title>GIN’n’CIN hypothesis of brain aging: deciphering the role of somatic genetic instabilities and neural aneuploidy during ontogeny</article-title>. <source/>Mol. Cytogenet
<volume>2</volume>, <fpage>23</fpage>. <pub-id pub-id-type="doi">10.1186/1755-8166-2-23</pub-id>
<pub-id pub-id-type="pmid">19939257</pub-id></mixed-citation>
</ref>
<ref id="B125">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yurov</surname><given-names>Y. B.</given-names></name><name><surname>Vorsanova</surname><given-names>S. G.</given-names></name><name><surname>Iourov</surname><given-names>I. Y.</given-names></name></person-group> (<year>2010</year>). <article-title>Ontogenetic variation of the human genome</article-title>. <source/>Curr. Genomics
<volume>11</volume> (<issue>6</issue>), <fpage>420</fpage>–<lpage>425</lpage>. <pub-id pub-id-type="doi">10.2174/138920210793175958</pub-id>
<pub-id pub-id-type="pmid">21358986</pub-id></mixed-citation>
</ref>
<ref id="B126">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yurov</surname><given-names>Y. B.</given-names></name><name><surname>Vorsanova</surname><given-names>S. G.</given-names></name><name><surname>Iourov</surname><given-names>I. Y.</given-names></name></person-group> (<year>2011</year>). <article-title>The DNA replication stress hypothesis of Alzheimer’s disease</article-title>. <source/>ScientificWorldJournal
<volume>11</volume>, <fpage>2602</fpage>–<lpage>2612</lpage>. <pub-id pub-id-type="doi">10.1100/2011/625690</pub-id>
<pub-id pub-id-type="pmid">22262948</pub-id></mixed-citation>
</ref>
<ref id="B127">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yurov</surname><given-names>Y. B.</given-names></name><name><surname>Vorsanova</surname><given-names>S. G.</given-names></name><name><surname>Iourov</surname><given-names>I. Y.</given-names></name><name><surname>Demidova</surname><given-names>I. A.</given-names></name><name><surname>Beresheva</surname><given-names>A. K.</given-names></name><name><surname>Kravetz</surname><given-names>V. S.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Unexplained autism is frequently associated with low-level mosaic aneuploidy</article-title>. <source/>J. Med. Genet.
<volume>44</volume> (<issue>8</issue>), <fpage>521</fpage>–<lpage>525</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.2007.049312</pub-id>
<pub-id pub-id-type="pmid">17483303</pub-id></mixed-citation>
</ref>
<ref id="B128">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>Hemmerich</surname><given-names>P.</given-names></name><name><surname>Grosse</surname><given-names>F.</given-names></name></person-group> (<year>2007</year>). <article-title>Centrosomal localization of DNA damage checkpoint proteins</article-title>. <source/>J. Cell Biochem.
<volume>101</volume> (<issue>2</issue>), <fpage>451</fpage>–<lpage>465</lpage>. <pub-id pub-id-type="doi">10.1002/jcb.21195</pub-id>
<pub-id pub-id-type="pmid">17171639</pub-id></mixed-citation>
</ref>
<ref id="B129">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhao</surname><given-names>C.</given-names></name><name><surname>Deng</surname><given-names>W.</given-names></name><name><surname>Gage</surname><given-names>F. H.</given-names></name></person-group> (<year>2008</year>). <article-title>Mechanisms and functional implications of adult neurogenesis</article-title>. <source/>Cell
<volume>132</volume> (<issue>4</issue>), <fpage>645</fpage>–<lpage>660</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2008.01.033</pub-id>
<pub-id pub-id-type="pmid">18295581</pub-id></mixed-citation>
</ref>
<ref id="B130">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zheng</surname><given-names>W.</given-names></name><name><surname>ZhuGe</surname><given-names>Q.</given-names></name><name><surname>Zhong</surname><given-names>M.</given-names></name><name><surname>Chen</surname><given-names>G.</given-names></name><name><surname>Shao</surname><given-names>B.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Neurogenesis in adult human brain after traumatic brain injury</article-title>. <source/>J. Neurotrauma
<volume>30</volume> (<issue>22</issue>), <fpage>1872</fpage>–<lpage>1880</lpage>. <pub-id pub-id-type="doi">10.1089/neu.2010.1579</pub-id>
<pub-id pub-id-type="pmid">21275797</pub-id></mixed-citation>
</ref>
<ref id="B131">
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhou</surname><given-names>L.</given-names></name><name><surname>Del Villar</surname><given-names>K.</given-names></name><name><surname>Dong</surname><given-names>Z.</given-names></name><name><surname>Miller</surname><given-names>C. A.</given-names></name></person-group> (<year>2004</year>). <article-title>Neurogenesis response to hypoxia-induced cell death: map kinase signal transduction mechanisms</article-title>. <source/>Brain Res.
<volume>1021</volume> (<issue>1</issue>), <fpage>8</fpage>–<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2004.05.115</pub-id>
<pub-id pub-id-type="pmid">15328027</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>